Introduction {#s1}
============

The developing nervous system must generate, organize, and refine billions of neurons and their connections. While molecular guidance cues forge globally precise neuronal connections between distant brain areas ([@bib12]; [@bib48]), the organization of local connections is initially coarse and imprecise ([@bib11]; [@bib24]; [@bib47]). Coincident with the refinement of topographic maps, nascent circuits experience bursts of intrinsically generated activity that emerge before sensory systems are fully functional ([@bib24]). This intrinsically generated activity consists of periodic bursts of high frequency firing that promotes the survival and maturation of neurons in sensory pathways ([@bib4]; [@bib33]). The precise patterning of this electrical activity appears crucial for refinement of local connections, as its disruption results in improper formation of topographic maps ([@bib2]; [@bib7]; [@bib62]) and impaired maturation and specification of sensory neurons ([@bib44]; [@bib49]). In all sensory systems that have been examined, spontaneous burst firing arises within their respective developing sensory organs (e.g. retina, olfactory neuroepithelium, and cochlea) ([@bib4]; [@bib64]). Although the mechanisms that induce spontaneous activity in the developing retina have been extensively explored, much less is known about the key steps involved in triggering auditory neuron burst firing in the developing cochlea. Understanding these processes may provide novel insights into the causes of developmental disorders of hearing, such as hypersensitivity to sounds and auditory processing disorders that prevent children from communicating and learning effectively.

The mechanisms responsible for initiating spontaneous activity appear to be unique to each sensory system, reflecting adaptations to the structure and cellular composition of the sensory organs. In the cochlea, two distinct models have been proposed to initiate burst firing of inner hair cells (IHCs). One model proposes that the initiation of burst firing results from intermittent hyperpolarization of tonically active IHCs by cholinergic efferents ([@bib22]; [@bib61]), which provide prominent inhibitory input to IHCs prior to hearing onset ([@bib17]). While transient activation of acetylcholine receptors in acutely isolated cochleae caused IHCs to switch from sustained to burst firing ([@bib22]), in vivo recordings from auditory brainstem revealed that neuronal burst firing remains, with altered temporal structure, in α9 acetylcholine receptor knockout (KO) mice ([@bib9]) that lack functional efferent signaling in IHCs ([@bib9]; [@bib23]). Burst firing also persists in IHCs and auditory neurons in cochleae maintained in vitro without functional efferents ([@bib23]; [@bib52]). These findings suggest that cholinergic efferents modulate the temporal characteristics of bursts, but are not essential to initiate each event.

An alternative model proposes that IHCs are induced to fire bursts of action potentials by the release of K^+^ from nearby inner supporting cells (ISCs), which together form a transient structure known as Köllikers organ (Greater Epithelial Ridge) that is prominent in the cochlea prior to hearing onset. K^+^ release from ISCs occurs following a cascade of events that begins with the spontaneous release of ATP and activation of purinergic autoreceptors ([@bib53]). Purinergic receptor activation induces an increase in intracellular Ca^2+^ in ISCs, opening of Ca^2+^-activated Cl^--^ channels (TMEM16A), efflux of Cl^--^ and subsequently K^+^ to balance charge ([@bib52]; [@bib60]). The loss of ions during each event draws water out of ISCs through osmosis, leading to pronounced shrinkage (crenation) of ISCs. While these pathways have been extensively studied in vitro, the molecular identity of the purinergic receptors has remained elusive and few manipulations of this pathway have been performed in vivo, limiting our understanding of how spontaneous activity in the cochlea influences patterns of neuronal activity in auditory centers at this critical stage of development.

Here, we show that the key initial step in generation of spontaneous activity in the auditory system involves activation of P2RY1 autoreceptors in ISCs. These metabotropic receptors induce Ca^2+^ release from intracellular stores that allow TMEM16A channels to open. Pharmacological inhibition of P2RY1 or genetic deletion of *P2ry1* dramatically reduced burst firing in spiral ganglion neurons (SGNs) and blocked the coordinated, spatially restricted activation of ISCs, IHCs, and SGNs in the cochlea. Unexpectedly, P2RY1 activation also promoted the dissipation of K^+^ away from IHCs by increasing the volume of extracellular space. Conversely, inhibition of P2RY1 reduced the extracellular space and restricted the redistribution of K^+^ within the cochlear epithelium, causing IHCs to depolarize and fire tonically, demonstrating an important role for purinergic receptor-mediated extracellular space changes in controlling IHC excitability. Using in vivo widefield epifluorescence imaging of the auditory midbrain in unanesthetized mice, we show that acute inhibition of P2Y1 dramatically reduced burst firing of auditory neurons in isofrequency domains. Together, these data indicate P2RY1 autoreceptors in non-sensory supporting cells in the cochlea play a crucial role in generating bursts of activity among neurons that will ultimately process similar frequencies of sound, providing the means to initiate the maturation of auditory pathways before hearing onset.

Results {#s2}
=======

Supporting cell spontaneous currents require calcium release from intracellular stores {#s2-1}
--------------------------------------------------------------------------------------

Periodic release of ATP from ISCs in the developing cochlea initiates a signaling cascade in these cells that increases intracellular calcium (Ca^2+^), opens Ca^2+^-activated Cl^--^ channels (TMEM16A), and ultimately results in efflux of chloride and K^+^ into the extracellular space. Although the increase in intracellular Ca^2+^ following activation of purinergic autoreceptors is sufficient to induce both depolarization and osmotic shrinkage ([@bib60]), the relative contributions of Ca^2+^ influx (e.g. through Ca^2+^-permeable, ionotropic P2X receptors) and release from intracellular stores (e.g. following metabotropic P2Y receptor activation) to these cytosolic Ca^2+^ transients is unclear. To define the signaling pathways engaged by purinergic receptor activation, we examined the sensitivity of spontaneous ISC whole-cell currents and crenations to inhibitors of intracellular Ca^2+^ release pathways ([Figure 1A](#fig1){ref-type="fig"}). Spontaneous inward currents and crenations were abolished following a 15 min incubation of excised cochlea in BAPTA-AM (100 μM), a cell permeant Ca^2+^ chelator ([Figure 1B--F](#fig1){ref-type="fig"}), and after depleting intracellular Ca^2+^ stores with thapsigargin (2 μM), an inhibitor of endoplasmic reticulum Ca^2+^-ATPase ([Figure 1B--F](#fig1){ref-type="fig"}). These data suggest that Ca^2+^ release from intracellular stores is necessary for spontaneous electrical activity in ISCs.

![Ca^2+^ release from intracellular stores is required for spontaneous currents and crenation in inner supporting cells.\
(**A**) Model of ATP-mediated depolarization of inner hair cells. ATP: adenosine triphosphate, PLC: phospholipase C, IP~3~: inositol triphosphate, TMEM16A: transmembrane member 16A (Ca^2+^-activated Cl^--^ channel). Inhibitors of key steps in this pathway are indicated. (**B**) Whole-cell voltage-clamp recordings from inner supporting cells after pre-incubating with indicated inhibitors. (**C**) Quantification of ISC spontaneous current frequency in the presence of the indicated inhibitors. Data shown as mean ± SEM. n = 16 cells, 11 cochleae from six postnatal day (P) 6--8 rats (control), 18 cells, 10 cochleae from five rats (BAPTA-AM; 100 μM), 20 cells, 11 cochleae from six rats (Thapsigargin; 2 μM), 14 cells, 11 cochleae from seven rats, (U73122; 10 μM), and 16 cells, 10 cochleae from five rats (U73343; 10 μM). \*\*\*\*p\<5e-5, one-way ANOVA. (**D**) Quantification of ISC spontaneous current amplitude in the presence of indicated inhibitors. Data shown as mean ± SEM. n values are reported in (**C**) (one-way ANOVA; \*\*\*\*p\<5e-5, \*\*p\<0.005, ns: not significant). (**E**) Quantification of ISC spontaneous current charge transfer (integral) in the presence of indicated inhibitors. Data shown as mean ± SEM. n values are reported in (**C**) (one-way ANOVA; \*\*\*\*p\<5e-5, \*\*p\<0.005, ns: not significant). (**F**) Quantification of ISC crenation (cell shrinkage) frequency in the presence of indicated inhibitors. Data shown as mean ± SEM. n = 19 videos, 11 cochleae from six rats (control), 15 videos, 8 cochleae from four rats (BAPTA-AM), 22 videos, 12 cochleae from six rats (Thapsigargin), 23 videos, 17 cochleae from 10 rats (U73122), and 20 videos, 10 cochleae from five rats (U73343) (one-way ANOVA; \*\*\*\*p\<5e-5, \*\*p\<0.005, ns: not significant). See [Figure 1---source data 1](#fig1sdata1){ref-type="supplementary-material"} for plotted values and statistics.\
Figure 1---source data 1.Plotted values and statistics for [Figure 1](#fig1){ref-type="fig"}.](elife-52160-fig1){#fig1}

Metabotropic G~q~-coupled receptors typically induce PLC-mediated cleavage of phosphatidylinositol 4,5-bisphosphate (PIP2) and subsequent binding of inositol trisphosphate (IP~3~) to IP~3~ receptor-channels on the endoplasmic reticulum to release Ca^2+^ into the cytoplasm. To determine if PLC signaling is necessary to generate spontaneous activity in ISCs, we recorded spontaneous currents and crenations from ISCs in the presence of U73122 (10 μM), a PLC inhibitor, and U73343 (10 μM), an inactive succinimide analog. The frequency of spontaneous currents and crenations were significantly reduced by U73122, but not by U73343 ([Figure 1B--F](#fig1){ref-type="fig"}); the amplitudes and charge transfer of residual activity also trended lower during PLC inhibition, but this did not reach significance due to high variance in the sizes of the spontaneous responses ([Figure 1B--F](#fig1){ref-type="fig"}). Intracellular Ca^2+^ stores can also be mobilized through calcium-induced calcium release (CICR) involving ryanodine receptors. However, neither spontaneous currents nor crenations were affected by ryanodine (10 μM) ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Together, these results suggest that engagement of a G~q~-coupled purinergic autoreceptor is a critical first step in initiating PLC-mediated Ca^2+^ release from intracellular stores and subsequent activation of TMEM16A channels.

The metabotropic purinergic receptor P2Y1 is highly expressed by supporting cells {#s2-2}
---------------------------------------------------------------------------------

There are eight members of the metabotropic purinergic receptor family in mouse, four of which are G~q~-coupled (P2RY1, P2RY2, P2RY4, and P2RY6). Gene expression studies in the developing mouse cochlea revealed that non-sensory cells express P2RY1 mRNA at high levels, \>100 fold higher than any other P2RY ([Figure 2A](#fig2){ref-type="fig"}; [@bib42]) and that expression of this receptor progressively increases during early postnatal development ([Figure 2A](#fig2){ref-type="fig"}, inset) concurrent with increases in spontaneous activity ([@bib55]). To determine which cells in the sensory epithelium express P2RY1, we isolated cochleae from *P2ry1-LacZ* reporter mice and performed X-gal staining. Intense blue labeling was present along the entire length of the cochlea within Kölliker's organ (Greater Epithelial Ridge; [Figure 2B](#fig2){ref-type="fig"}), and cross-sections of cochlea revealed that staining was present within ISCs, but not IHCs (Myosin VIIA, [Figure 2C](#fig2){ref-type="fig"}), indicating that P2RY1 is appropriately localized to sense ATP release from ISCs prior to hearing onset.

![The metabotropic P2Y1 receptor is highly expressed by ISCs.\
(**A**) Expression levels of metabotropic purinergic receptors in hair cells (gray) and non-sensory cells (black) of the developing cochlea (postnatal day 7, P7). (inset) *P2ry1* expression in non-sensory cells over development. Data adapted from [@bib42]. (**B**) Image of a cochlea following X-gal reaction in *P2ry1* LacZ reporter mice. (**C**) Immunostaining for B-galactosidase in cochleae from P7 *P2ry1* LacZ (top) and control (bottom) cochlea.](elife-52160-fig2){#fig2}

P2RY1 signaling is required for spontaneous activity in ISCs and IHCs {#s2-3}
---------------------------------------------------------------------

To determine if P2RY1 is responsible for spontaneous ATP-mediated currents in ISCs, we examined the sensitivity of these responses and associated crenations to the P2RY1 selective antagonist MRS2500 ([Figure 3A,B](#fig3){ref-type="fig"}). Acute inhibition of P2RY1 with MRS2500 (1 µM) markedly reduced both spontaneous ISC currents ([Figure 3B,C](#fig3){ref-type="fig"}) and crenations ([Figure 3D,E](#fig3){ref-type="fig"}); near complete inhibition occurred within minutes at both room temperature ([Figure 3B,C](#fig3){ref-type="fig"}) and near physiological temperature ([Figure 3---figure supplement 1A--G](#fig3s1){ref-type="fig"}), with only sporadic, small amplitude events remaining that were not mediated by purinergic receptors ([Figure 3---figure supplement 1B--E](#fig3s1){ref-type="fig"}). Consistent with the involvement of P2RY1, the amplitude and total charge transfer of ISC events ([Figure 3---figure supplement 2A,B](#fig3s2){ref-type="fig"}) and size of spontaneous crenations ([Figure 3---figure supplement 2C,D](#fig3s2){ref-type="fig"}) were smaller in cochleae in *P2ry1* KO mice relative to controls. However, supporting cells in *P2ry1* KO mice exhibited some aberrant, gain-of-function activity consisting of more frequent, small amplitude currents ([Figure 3---figure supplement 2A,B](#fig3s2){ref-type="fig"}), that were not blocked by MRS2500 or broad-spectrum P2 receptor antagonists ([Figure 3---figure supplement 2E,F](#fig3s2){ref-type="fig"}).

![P2Y1 inhibition abolishes spontaneous currents in inner supporting cells and inner hair cells.\
(**A**) Schematic of whole-cell recording configuration from ISCs. (**B**) Spontaneous inward currents recorded from an inner supporting cell before and during application of MRS2500 (1 μM). Recordings were performed at room temperature (\~25°C). (**C**) Plot of event frequency, amplitude, and integral (charge transfer) before and after application of MRS2500. Measurement periods were five minutes long. n = 9 ISCs, 9 cochleae from 8 P6-8 mice (two-tailed paired Student's t test; \*\*\*\*p\<5e-5, \*\*\*p\<0.0005) (**D**) Intrinsic optical imaging performed before and after application of the P2RY1 antagonist, MRS2500 (1 μM). Detected crenations are outlined in colors based on time of occurrence as indicated by timeline below image. Imaging was performed at room temperature (\~25°C). (**E**) Plot of crenation frequency and area before and after application of MRS2500. n = 8 videos, 8 cochleae from 8 P6-8 mice (two-tailed paired Student\'s t test; \*\*p\<0.005) for frequency calculation and n = 5 cochleae (two-tailed paired Student\'s t test; \*p\<0.05) for area calculation. Cochleae that did not crenate after MRS2500 were excluded from the area calculation. (**F**) Schematic of whole-cell recording configuration from IHCs. (right) Whole-cell voltage clamp recording from an IHC before and during application of MRS2500. (**G**) Plots of event frequency and amplitude before and after application of MRS2500. n = 6 IHCs, 6 cochleae from 6 P6-8 mice (two-tailed paired Student\'s t test with Bonferroni correction; \*\*p\<0.005, \*p\<0.05). (**H**) Whole-cell voltage clamp recording of an ISC with application of MRS2500 following pre-incubation in aCSF containing CdCl~2~ (100 μM), TTX (1 μM), ouabain (10 μM), and bumetanide (50 μM) to limit potassium release into the extracellular space. (**I**) Plot of the change in holding current, defined as the 95% percentile current value for each period. n = 6 ISCs, 6 cochleae from 6 P6-8 mice for each condition (two-tailed Student's t test; \*\*\*p\<0.0005). (**J**) Whole-cell voltage clamp recording of an IHC with a Cs-TEA internal solution (to inhibit K+ channels) before and after MRS2500 application. (**K**) Plot of the change in IHC holding current following control (superfusion of aCSF only) and MRS2500 with K-MeS and Cs-TEA internal. n = 5 IHCs, 4 cochleae from 4 P6-8 mice for aCSF, n = 6 IHCs, 6 cochleae from six mice for MRS2500, n = 4 IHCs, 3 cochleae from three mice for aCSF with Cs-TEA internal, and n = 6 IHCs, 6 cochleae from six mice for MRS2500 with Cs-TEA internal (one-way ANOVA; \*\*\*p\<0.005, \*\*p\<0.005, ns, not significant). See [Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"} for plotted values and statistics.\
Figure 3---source data 1.Plotted values and statistics for [Figure 3](#fig3){ref-type="fig"}.](elife-52160-fig3){#fig3}

ATP-mediated signaling in ISCs activates TMEM16A, triggering K^+^ efflux that depolarizes nearby IHCs. To assess whether P2RY1 signaling is also required for periodic excitation of IHCs prior to hearing onset, we assessed the sensitivity of spontaneous IHC inward currents to MRS2500 ([Figure 3F](#fig3){ref-type="fig"}). Consistent with the supporting cell origin of IHC activity, application of MRS2500 (1 µM) also abolished spontaneous currents in IHCs ([Figure 3F,G](#fig3){ref-type="fig"}). Together, these data suggest that P2RY1 is the primary purinergic autoreceptor on ISCs responsible for inducing periodic excitation of IHCs prior to hearing onset.

P2RY1 inhibition leads to extracellular K^+^ accumulation {#s2-4}
---------------------------------------------------------

Although P2RY1 inhibition abolished most transient inward currents in both ISCs and IHCs, a progressively increasing inward current (downward shift in baseline) appeared in both cell types with prolonged application of MRS2500 ([Figure 3B,F](#fig3){ref-type="fig"}). Prior studies in CNS brain slices indicated that G~q~-coupled purinergic receptors in astrocytes regulate extracellular K^+^ concentration and neuronal excitability ([@bib59]). The slowly progressing nature of the response in IHCs and ISCs suggest that it may arise from accumulation of K^+^ released from cells in the organ of Corti. If this hypothesis is correct, then inhibiting the main sources of extracellular K^+^ should diminish this inward current. Indeed, when IHC and SGN excitation was inhibited with cadmium (CdCl~2~, 100 µM) and tetrodotoxin (TTX, 1 µM), and K^+^ transporters Na,K-ATPase and NKCC were inhibited with ouabain (10 µM) and bumetanide (50 µM), no inward current was induced in ISCs upon blocking P2RY1 ([Figure 3H,I](#fig3){ref-type="fig"}). Similarly, if K^+^ accumulation is responsible for the current in IHCs, it should be abolished when the ability of IHCs to detect changes in K^+^ is reduced. When whole cell recordings were performed from IHCs using an internal solution containing Cs^+^ and TEA, which blocks most IHC K^+^ channels ([@bib26]; [@bib31]), MRS2500 also did not induce an inward current ([Figure 3J,K](#fig3){ref-type="fig"}). Together, these results suggest that P2RY1 has two distinct effects in the cochlea; it induces the transient inward currents that trigger IHC burst firing ([Figure 3F](#fig3){ref-type="fig"}; see also Figure 6D,G) and it accelerates clearance of K^+^ away from IHCs within the organ of Corti.

To directly assess the relationship between P2RY1 activity and extracellular K^+^ accumulation near IHCs, we monitored K^+^ levels in the extracellular space using IHC K^+^ channels. Focal P2RY1 stimulation with a selective agonist (MRS2365, 10 μM), which mimics the effect of endogenous ATP by eliciting an inward current and crenations in ISCs in control but not *P2ry1* KO mice ([Figure 4A--C](#fig4){ref-type="fig"}), was combined with assessments of the reversal potential of K^+^ currents in IHCs using a voltage protocol similar to that used to assess extracellular K^+^ buildup at vestibular calyceal synapses ([@bib29]) ([Figure 4D--F](#fig4){ref-type="fig"}). This protocol consisted of: (1) a hyperpolarizing step to --110 mV to relieve K^+^ channel inactivation, (2) a depolarizing step to +30 mV to activate outward K^+^ currents, and (3) a step to --70 mV to obtain a 'tail' current. Because the conductance during this last step is largely mediated by K^+^ channels, it is highly sensitive to shifts in K^+^ driving force induced by changes in extracellular K^+^ ([@bib10]; [@bib29]). Following transient stimulation of P2RY1, these K^+^ tail currents immediately shifted inward, as would be expected if extracellular K^+^ increases ([Figure 4G,J](#fig4){ref-type="fig"}), consistent with the effects metabotropic purinergic receptor stimulation on synaptically-evoked K^+^ currents in IHCs ([@bib60]). However, after a few seconds these K^+^ currents shifted outward relative to baseline, indicative of a gradual decrease in extracellular K^+^ below that present prior to P2RY1 stimulation, before gradually returning to pre-stimulation levels after several minutes ([Figure 4G,J](#fig4){ref-type="fig"}).

![Activation of P2RY1 results in an initial accumulation of extracellular K^+^, followed by crenation and enhanced K^+^ clearance.\
(**A**) Schematic of whole-cell recording configuration from ISCs with puffs of MRS2365 (10 μM), a P2RY1 agonist. (**B**) Optical change (crenation) and current elicited with MRS2365 puffs in wildtype and *P2ry1* KO mice (**C**) Plot of mean current amplitude with MRS2365 puffs. n = 8 ISCs, 8 cochleae from 4 P6-8 wildtype mice and n = 7 ISCs, 7 cochleae from four from P2ry1 KO mice (two-tailed Student's t test; \*\*p\<0.005). (**D**) Schematic of whole-cell recording configuration from IHCs with puffs of MRS2365 (10 μM). (**E**) Example current trace and voltage-protocol designed to measure potassium accumulation. This protocol consisted of: (1) a hyperpolarizing step to −110 mV to relieve K^+^ channel inactivation, (2) a depolarizing step to +30 mV to activate outward K^+^ currents, and (3) a step to −70 mV to obtain a 'tail' current. Dashed box indicated tail current measurement period indicated in (**F**). (**F**) Tail currents observed during baseline, immediately following the MRS2365 puff (with 2 s), and after the puff (30 s). (**G**) Model of K^+^ dynamics following MRS2365 stimulation. Initially, extracellular K^+^ rapidly increases following stimulation, but ISCs crenate, increasing the amount of extracellular space and K^+^ buffering. (bottom) Exemplar optical change (crenation), holding current, and tail current as a function of time with respect to MRS2365 puff. (**H**) Similar to G, but with KCl puffs (130 μM) in cochleae treated with MRS2500. (**I**) Similar to G, but in *Tecta-Cre;TMEM16A^fl/fl^* mice where TMEM16A has been conditionally removed from the sensory epithelium (see [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). No crenations were observed with MRS2365 stimulation. (**J**) Group tail currents across conditions from G-I. Gray lines indicate individual recordings; black points indicate the mean. Baseline was normalized to 0 pA for all traces. n = 12 IHCs, 11 cochleae from 9 P6-8 wildtype mice with MRS2365 stimulation, n = 5 IHCs, 5 cochleae from five wildtype mice with KCl stimulation, and n = 8 IHCs, 8 cochleae from 5 *Tecta-Cre;TMEM16A^fl/fl^* mice with MRS2365 stimulation. See [Figure 4---source data 1](#fig4sdata1){ref-type="supplementary-material"} for plotted values and statistics.\
Figure 4---source data 1.Plotted values and statistics for [Figure 4](#fig4){ref-type="fig"}.](elife-52160-fig4){#fig4}

The outward shift in K^+^ tail current closely followed the time course of supporting cell crenation ([Figure 4G](#fig4){ref-type="fig"}), suggesting that the shrinkage of ISCs induced by P2RY1 activation results in a prolonged increase in extracellular space around IHCs that allows greater dilution and more rapid redistribution of K^+^ in the organ of Corti. Alternatively, buildup of extracellular K^+^ alone may stimulate greater uptake. To determine if rapid increases in extracellular K^+^ and Cl^--^ were sufficient to stimulate K^+^ redistribution in the absence of crenation, we focally applied KCl (130 mM) into the supporting cell syncytium near IHCs in the presence of P2RY1 antagonists ([Figure 4H,J](#fig4){ref-type="fig"}). As expected, this transient increase in extracellular K^+^ induced an inward shift in K^+^ tail currents and a brief optical change induced by fluid delivery; however, K^+^ tail currents rapidly returned to baseline and did not shift outward, suggesting that extracellular K^+^ (and Cl^--^) elevation are not sufficient to enhance K^+^ redistribution rates. In addition, we transiently stimulated P2RY1 in *Tecta-Cre;TMEM16A*^fl/fl^ mice, in which purinergic receptor activation is preserved, but crenations are abolished ([@bib60]). In these mice, ISCs failed to crenate, IHCs did not depolarize, and K^+^ tail currents remained stable throughout the duration of the recording ([Figure 4I,J](#fig4){ref-type="fig"}). These results suggest that purinergic autoreceptors on ISCs influence extracellular K^+^ levels by triggering K^+^ release and by altering K^+^ redistribution by controlling the size of the extracellular space.

P2ry1 mediates coordinated neuronal activation and precise burst firing of SGNs {#s2-5}
-------------------------------------------------------------------------------

To evaluate the role of P2RY1 in initiating coordinated cellular activity in the cochlea, we monitored large-scale activity patterns in excised cochleae from *Pax2-Cre;R26-lsl-GCaMP3* mice, which express GCaMP3 in nearly all cells of the inner ear. Time lapse imaging revealed that the spontaneous Ca^2+^ elevations that occur simultaneously within groups of ISCs, IHCs, and SGNs ([@bib13]; [@bib55]; [@bib66]) ([Figure 5A](#fig5){ref-type="fig"}) were abolished following inhibition of P2RY1 with MRS2500 ([Figure 5B,C](#fig5){ref-type="fig"}) and were dramatically reduced in *P2ry1 KO* mice (*Pax2-Cre;R26-lsl-GCaMP3;P2ry1^--/--^*) ([Figure 5---figure supplement 1A,B](#fig5s1){ref-type="fig"}). Moreover, in accordance with the progressive increase in extracellular K^+^ that follows P2RY1 inhibition, there was a gradual increase in spontaneous, uncoordinated Ca^2+^ transients in IHCs in the presence of MRS2500 ([Figure 5D--F](#fig5){ref-type="fig"}), suggesting that this K^+^ accumulation increases IHC firing. Similarly, IHCs in *P2ry1* KO mice displayed a higher level of uncorrelated Ca^2+^ transients in hair cells ([Figure 5---figure supplement 1C--E](#fig5s1){ref-type="fig"}), indicative of enhanced excitability. Together, these results indicate that P2RY1 is required for coordinated activation of ISCs, IHCs, and SGNs before hearing onset and that P2RY1 inhibition leads to higher rates of uncorrelated activity.

![Large-scale coordinated activity in the cochlea requires P2RY1.\
(**A**) Exemplar Ca^2+^ transient in excised cochlea from *Pax2-Cre;R26-lsl-GCaMP3* mice. Note the coordinated activation of ISCs, IHCs, and SGNs. (**B**) Traces of fluorescence intensity over time taken from ROIs that span the entire IHC, ISC, and SGN regions indicated in (**A**). (**C**) Plot of event frequency before and during application of MRS2500 (1 μM). n = 5 cochleae from 3 P5+1DIV (day in vitro) *Pax2-Cre;R26-lsl-GCaMP3* mice (two-tailed paired Student\'s t test with Bonferroni correction; \*\*\*\*p\<5e-5, \*\*\*p\<0.0005). (**D**) Exemplar images of IHC Ca^2+^ transients. ROIs were drawn around every IHC for subsequent analysis (bottom). (**E**) Correlation matrices generated by calculating the linear correlation coefficient for all IHC pairs before and after MRS2500 application. (**F**) Plot of average correlation coefficient calculated between the four nearest IHCs. n = 5 P5+1DIV (day in vitro) cochleae from 3 *Pax2-Cre;R26-lsl-GCaMP3* mice (two-tailed paired Student\'s t test with Bonferroni correction; \*\*\*p\<0.0005, ns, not significant). See [Figure 5---source data 1](#fig5sdata1){ref-type="supplementary-material"} for plotted values and statistics.\
Figure 5---source data 1.Plotted values and statistics for [Figure 5](#fig5){ref-type="fig"}.](elife-52160-fig5){#fig5}

IHCs in the developing cochlea exhibit regenerative Ca^2+^ spikes that strongly activate post-synaptic SGNs, resulting in bursts of action potentials that propagate to the CNS. To determine if P2RY1 initiates burst firing in SGNs, we recorded spontaneous activity from SGNs using juxtacellular recordings from their somata ([Figure 6A](#fig6){ref-type="fig"}). Application of MRS2500 resulted in a dramatic reduction of high frequency burst firing in SGNs, visible as a decrease in burst frequency and action potentials per burst ([Figure 6E,F](#fig6){ref-type="fig"}). All SGN spiking was abolished by the AMPA receptor antagonist NBQX (50 µM) ([Figure 6D](#fig6){ref-type="fig"}), indicating that their activity requires synaptic excitation by IHCs. The precise patterning of action potentials within bursts was also disrupted by P2RY1 inhibition, as there were fewer interspike intervals in the 75--125 ms range ([Figure 6C,F](#fig6){ref-type="fig"}), which correspond to the maximum rate of Ca^2+^ spike generation by IHCs during ATP-mediated excitation ([@bib54]). Additionally, the coefficient of variation measured for interspike intervals was significantly lower following P2RY1 inhibition, suggesting SGNs fire more randomly ([Figure 6E](#fig6){ref-type="fig"}). However, the average frequency of action potentials remained unchanged during P2RY1 inhibition ([Figure 6E](#fig6){ref-type="fig"}) due to increases in non-burst firing, consistent with depolarizing inward currents observed in IHCs with P2RY1 inhibition ([Figure 3F,K](#fig3){ref-type="fig"}). SGNs in *P2ry1* KO cochleae exhibited activity similar to wildtype SGNs in the presence of MRS2500, with a lower burst firing rate, fewer interspike intervals in the 75--125 ms range, and a lower coefficient of variation of interspike intervals relative to controls ([Figure 6G--I](#fig6){ref-type="fig"}). However, despite the profound contribution of P2RY1 to ISC and IHC activity, some burst-like behavior (clustered, but lacking the same density of action potentials in control conditions) was still observed in SGNs ([Figure 6C,D,G](#fig6){ref-type="fig"}) suggesting that other forms of excitation emerge in the absence of P2RY1, perhaps due to the increase in overall excitability or compensatory developmental changes. Together, these data indicate that P2RY1 is required to generate discrete bursts of action potentials in SGNs and that loss of these receptors enhances uncorrelated firing.

![Inhibition of P2ry1 disrupts burst firing in spiral ganglion neurons.\
(**A**) Schematic of the juxtacellular recording configuration used to assess spiral ganglion neurons (SGNs). All SGN recordings were performed at room temperature. (**B**) Action potentials recorded before and during application of MRS2500 (1 μM). Detected bursts are indicated in green (see Materials and methods and Materials for parameters used for burst detection). Circle with black and red outlines are expanded in (**C**). (**C**) Action potentials within a detected burst before and after MRS2500 application. (**D**) Raster plots indicating the average firing rate of SGNs (bin: 1 s) before and during application of MRS2500 (1 μM) and subsequent NBQX (50 μM) (**E**) Plots of average burst frequency, burst duration, action potentials (AP) per burst, average AP frequency, and coefficient of variation for all interspike intervals (ISIs) measured. n = 7 SGNs, 7 P5+2DIV cochleae from six wildtype mice (two-tailed paired Student\'s t-test with Bonferroni correction; \*\*\*p\<0.0005, \*p\<0.05, ns, not significant). (**F**) Average log-binned interspike interval histograms before and after MRS2500 application. (**G**) Raster plots indicating the average firing rate of SGNs (bin: 1 s) in wildtype and *P2ry1 KO* mice. (**H**) Plots of average burst frequency, burst duration, action potentials (AP) per burst, average AP frequency, and coefficient of variation for all ISIs measured. n = 10 SGNs, 10 P5+2DIV cochleae from wildtype mice and 11 SGNs, 10 cochleae from 9 *P2ry1* KO mice (two-tailed Student\'s t-test with Bonferroni correction; \*\*\*\*p\<5e-5, \*\*p\<0.005, ns, not significant). (**I**) Average log-binned interspike interval histograms from wildtype and *P2ry1* KO SGN recordings. See [Figure 6---source data 1](#fig6sdata1){ref-type="supplementary-material"} for plotted values and statistics.\
Figure 6---source data 1.Plotted values and statistics for [Figure 6](#fig6){ref-type="fig"}.](elife-52160-fig6){#fig6}

P2RY1 promotes auditory neuron firing in vivo {#s2-6}
---------------------------------------------

The highly synchronized electrical activity exhibited by IHCs prior to hearing onset propagates through the entire developing auditory system to induce correlated firing of auditory neurons within isofrequency zones ([@bib3]; [@bib54]). To determine if P2RY1 is required to produce this form of correlated activity, we used in vivo wide-field epifluorescence microscopy of the inferior colliculus (IC) in mice that express GCaMP6s in all neurons (*Snap25-T2A-GCaMP6s* and *Snap25-T2A-GCaMP6s;P2ry1^--/--^* mice). Time lapse imaging revealed that both control and *P2ry1* KO mice exhibited correlated neuronal activity confined to stationary bands oriented along the tonotopic axis ([Figure 7A--C](#fig7){ref-type="fig"}). Spontaneous events were less frequent in *P2ry1* KO mice (9.7 ± 0.8 events per minute compared to 13.4 ± 0.7 events per minute in control; two-tailed Student's t test, p=0.002), although the events were similar in amplitude and duration (half-width) ([Figure 7D](#fig7){ref-type="fig"}), suggesting that some compensatory amplification of events occurs in these mice. Spontaneous activity in *P2ry1* KO mice differed from controls in three other ways. First, the contralateral bias exhibited for each event was higher, with the weaker relative to stronger side amplitude decreasing from 0.61 ± 0.02 to 0.44 ± 0.02 (two-tailed Student's t test, p=3.0e-6) ([Figure 7D](#fig7){ref-type="fig"}). Second, the coefficient of variation (ratio of standard deviation to the mean) of event amplitudes was 40% higher relative to controls ([Figure 7D](#fig7){ref-type="fig"}). Third, a detailed examination of the spatial location of events across the tonotopic axis ([Figure 7E](#fig7){ref-type="fig"}) revealed that activity in brain areas later responsible for processing higher frequency tones (\~8--16 kHz) exhibited the greatest reduction (68%) in *P2ry1 KO* mice, while activity in low frequency areas was unaltered ([Figure 7F--H](#fig7){ref-type="fig"}). In *P2ry1 KO* mice, bilateral removal of both cochleae abolished activity in the IC, demonstrating that activity in these mice still originates in the periphery ([Figure 7---figure supplement 1A--C](#fig7s1){ref-type="fig"}).

![*P2ry1* KO mice exhibit reduced and spatially restricted spontaneous activity in the inferior colliculus.\
(**A**) Diagram illustrating flow of information through the auditory system and average intensity image over the 10 min imaging session. (middle) Activity over time in left and right IC in an individual where each line indicates the fluorescence intensity of each detected event; the circle indicates the dominant lobe, and the size of the circle indicated the difference in fluorescence. (bottom) Histograms showing the frequency of dominant events of a given amplitude for this experiment and for all experiments. Imaging was performed in *Snap25-T2A-GCaMP6s* mice (n = 9 mice). (**B**) Similar to (**A**), but in *Snap25-T2A-GCaMP6s;P2ry1^--/--^* (*P2ry1* KO) mice (n = 7 P6-8 mice). (**C**) Images of spontaneous events in the IC of in control (*Snap25-T2A-GCaMP6s)* and P2ry1 KO mice (*Snap25-T2A-GCaMP6s;P2ry1^--/--^)*. (**D**) Comparisons of average frequency, amplitude, half-width, and event ratio from control and *P2ry1* KO mice. Bilateral amplitude ratio was calculated for events simultaneous across both lobes of the IC and defined as the ratio of the weak to the strong side amplitude. A ratio of 1 would indicate complete synchrony between lobes; a ratio of 0 would indicate complete asymmetry. n = 9 control and n = 7 *P2ry1* KO P6-8 mice (two-tailed Student's t test with Bonferroni correction; \*\*\*\*p\<5e-4, \*\*p\<0.005, ns: not significant). (**E**) Exemplars of a single-banded event. Rectangular ROIs were placed as shown and averaged to create a \`line-scan\' across the tonotopic axis. (bottom) Heat maps of activity as a function of time and distance; circles indicate detected peaks. (**F**) Activity over a five-minute time frame in the left and right IC of control and *P2ry1* KO mice. Circles indicate detected peaks. (bottom) Histograms of peak locations. (**G**) Histogram of average number of events across all control (black) and *P2ry1* KO (red) mice. (bottom) Cumulative distribution function of event locations across the tonotopic axis pooled from all animals. Events from left and right IC were combined for each experiment. (**H**) Quantification of event frequency in the medial (low frequency) and lateral (high frequency) regions of the IC. n = 9 control and 7 *P2ry1* KO P6-8 mice (two-tailed Student\'s t test with Bonferroni correction; \*\*\*\*p\<5e-5, ns, not significant). See [Figure 7---source data 1](#fig7sdata1){ref-type="supplementary-material"} for plotted values and statistics.\
Figure 7---source data 1.Plotted values and statistics for [Figure 7](#fig7){ref-type="fig"}.](elife-52160-fig7){#fig7}

Although *P2ry1* KO mice mimic some aspects of acute P2RY1 inhibition, the absence of P2RY1 signaling throughout life may have led to compensatory changes, such as the increase in non-purinergic ISC activity (see [Figure 3---figure supplement 2E](#fig3s2){ref-type="fig"}). Therefore, to better assess the role of P2RY1 in generating spontaneous activity in vivo, we acutely inhibited these receptors by administering MRS2500 into the intraperitoneal cavity of mice while imaging activity in the IC. Compared to mice injected with control solution (5% mannitol), mice injected with MRS2500 exhibited dramatic reductions in IC event frequency (from 13.3 ± 0.8 to 3.9 ± 1.1 events per minute; two-tailed Student's t test, p=0.0005) and amplitude (from 9.9 ± 0.5 to 4.9 ± 0.8% ΔF/F~o~; two-tailed Student's t test, p=0.002)\~5 min after administration ([Figure 8A--D](#fig8){ref-type="fig"}). This decrease was specific to the IC, as SC retinal wave activity ([@bib1]) was unaffected by acute MRS2500 administration ([Figure 8B,C,E](#fig8){ref-type="fig"}), suggesting that the locus of action is likely within the cochlea, which has been shown to have a permeable blood-tissue barrier at this age ([@bib50]). Spatial analysis revealed that unlike the selective deficit observed in higher frequency zones in *P2ry1* KO mice, the inhibition with MRS2500 administration was not limited to certain tonotopic regions, but rather occurred evenly across all frequency zones ([Figure 8F,G](#fig8){ref-type="fig"}). Together, these data indicate that P2RY1 autoreceptors on ISCs within the cochlea play a critical role in initiating spontaneous bursts of neural activity in auditory centers within the brain prior to hearing onset.

![Delivery of MRS2500 in vivo dramatically reduces spontaneous activity in the developing auditory system.\
(**A**) Diagram illustrating flow of information to the midbrain and the visual superior colliculus. Sham solution (5% mannitol) was injected via IP catheter during imaging. (bottom) Activity over time in left and right IC in an individual where each line indicates the fluorescence intensity of each detected event; the circle indicates the dominant lobe, and the size of the circle indicated the difference in fluorescence. Dashed line indicates time of injection. (**B**) Calcium transients in the midbrain, color-coded based on time of occurrence following sham injection. (bottom) Calcium transients observed in the left and right SC. (**C**) Similar to (**A**) and (**B**), but with injection of MRS2500 (50 μL of 500 μM MRS2500 in 5% mannitol solution). (**D**) Plot of IC event frequency and amplitude in sham and MRS2500 injected animals. n = 5 mice for each condition (two-tailed paired Student's t test with Bonferroni correction; \*\*\*p\<0.005, \*\*p\<0.005, ns: not significant). (**E**) Plot of SC wave frequency and duration in sham and MRS2500 injected animals. n = 5 P6-8 mice for each condition (two-tailed paired Student's t test with Bonferroni correction; ns: not significant). (**F**) Activity along the tonotopic axis over a five-minute time frame in the left and right IC before (left) and after (right) MRS2500 injection. Circles indicate detected peaks. (bottom) Histograms of peak locations. (**G**) Histogram of average number of events before (black) and after (red) MRS2500 injection. (bottom) Cumulative distribution function of event locations across the tonotopic axis pooled from all animals. Events from left and right IC were combined for each experiment. (**H**) Quantification of event frequency in the medial (low frequency) and lateral (high frequency) regions of the IC. n = 5 P6-8 mice (two-tailed Student\'s t test with Bonferroni correction; \*\*\*p\<0.005). See [Figure 8---source data 1](#fig8sdata1){ref-type="supplementary-material"} for plotted values and statistics.\
Figure 8---source data 1.Plotted values and statistics for [Figure 8](#fig8){ref-type="fig"}.](elife-52160-fig8){#fig8}

Discussion {#s3}
==========

Intense periods of neuronal activity dramatically alter the ionic composition of the extracellular environment, leaving behind excess K^+^ that can alter neuronal excitability, induce spontaneous activity and trigger debilitating seizures. In the CNS, homeostatic control of extracellular K^+^ levels is accomplished by glial cells, which redistribute K^+^ passively through ion channels and actively through facilitated transport, but much less is known about the mechanisms that control excitability in the peripheral nervous system. Sensory hair cells and primary auditory neurons in the cochlea are surrounded by supporting cells that share key features with CNS glia and are thought to redistribute K^+^ that accumulates during sound detection. However, prior to hearing onset, ATP-dependent K^+^ release from these cells triggers periodic bursts of activity in nearby IHCs that propagate throughout the auditory system. Here, we demonstrate that this form of intrinsically generated activity is initiated through activation of P2RY1, a G~q~-coupled metabotropic purinergic receptor. Acute inhibition or genetic removal of this receptor dramatically reduced spontaneous activity and disrupted burst firing in IHCs, SGNs and central auditory neurons. In addition to triggering episodic K^+^-dependent depolarization of hair cells, activation of P2RY1 also enhanced K^+^ clearance by increasing the volume of extracellular space, allowing more rapid dissipation of extracellular K^+^ transients. This duality of purpose, to induce K^+^ efflux and enhance K^+^ clearance, promotes discrete bursts of activity throughout the developing auditory system.

Purinergic signaling in the developing cochlea {#s3-1}
----------------------------------------------

Before the onset of hearing, neurons in the auditory system that will process similar sound frequencies exhibit periodic bursts of highly correlated activity, an entrainment that is initiated within the cochlea by the release of ATP ([@bib3]; [@bib9]; [@bib46]; [@bib54]). The mechanism of ATP release from ISCs within the developing cochlear epithelium remains undefined, but may involve gap-junction hemichannels, as gap-junction antagonists profoundly inhibit spontaneous activity and lowering extracellular calcium, a manipulation that increases the open probability of hemichannels ([@bib40]), markedly enhances the frequency of spontaneous activity ([@bib52]). Extruded ATP then activates ISC purinergic receptors, triggering a rapid increase of intracellular Ca^2+^, gating of TMEM16A Ca^2+^-activated Cl^--^ channels, and subsequent Cl^--^ and K^+^ efflux into the extracellular space ([@bib52]; [@bib60]). This transient K^+^ efflux is sufficient to depolarize nearby IHCs, resulting in a burst of Ca^2+^action potentials, release of glutamate, and suprathreshold activation of postsynaptic SGNs via AMPA and NMDA receptors ([@bib54]; [@bib66]) ([Figure 9A](#fig9){ref-type="fig"}). These bursts propagate throughout the entire developing auditory system ([@bib3]) and likely activate the olivocochlear efferent reflex arc, providing bursts of inhibition to IHCs that may modulate the envelope of excitation ([@bib9]) and/or the number of IHCs activated during each event. Our results show that activation of metabotropic P2RY1 autoreceptors is a key first step in this transduction pathway. P2RY1 is highly expressed by ISCs at a time when spontaneous activity is prominent in the cochlea ([@bib42]; [@bib55]) ([Figure 2A](#fig2){ref-type="fig"}), and spontaneous activity was reduced when intracellular Ca^2+^ stores were depleted or PLC was inhibited ([Figure 1B--F](#fig1){ref-type="fig"}), manipulations that disrupt canonical G~q~-coupled GPCR signaling pathways ([@bib14]; [@bib15]). Moreover, our pharmacological studies indicate that P2RY1 is both necessary and sufficient for spontaneous current generation in supporting cells ([Figures 3B](#fig3){ref-type="fig"} and [4B](#fig4){ref-type="fig"}), and acute inhibition of P2RY1 in vivo profoundly decreased cochlea-generated activity in the auditory midbrain ([Figure 8C](#fig8){ref-type="fig"}). This reliance on P2RY1 is somewhat unexpected, as ionotropic P2X and other metabotroic P2Y receptors are also widely expressed in the developing cochlea ([@bib6]; [@bib13]; [@bib20]; [@bib27]; [@bib30]; [@bib36]; [@bib42]; [@bib52]). The lack of P2X or other G~q~-coupled P2Y receptor engagement may reflect the particular spatial-temporal characteristics of ATP release by ISCs, which may occur in locations enriched in P2RY1 or yield ATP concentration transients that favor P2RY1 activation. Exogenous ATP can induce all of the phenomenon associated with spontaneous events (ISC currents, crenation, IHC depolarization, SGN burst firing); however, it is possible that other nucleotides are released that have greater affinity for P2RY1 (e.g. ADP), or that extracellular nucleotidases rapidly convert ATP to ADP that favor activation of native metabotropic receptors ([@bib58]; [@bib56]; [@bib57]).

![Summary of the dualistic action of P2Y1 signaling.\
(**A**) Spontaneous release of ATP and P2RY1 activation of ISCs initiates a cascade of intracellular signaling events that culiminates in a transient increase in extracellular K^+^ levels and depolarization of IHCs, resulting in burst firing. The large efflux of ions during each ATP event draws water out of ISCs through osmosis, leading to pronounced shrinkage (crenation) of ISCs and enhanced diffusion of K^+^ through the increased extracellular volume. (**B**) Inhibition or genetic removal of P2RY1 induces cellular swelling and loss of extracellular space, leading to extracellular K^+^ accumulation and tonic firing of IHCs.](elife-52160-fig9){#fig9}

Control of extracellular K^+^ dynamics by supporting cells {#s3-2}
----------------------------------------------------------

Pharmacological inhibition of P2RY1 unexpectedly induced IHCs to gradually depolarize and begin tonic, uncorrelated firing, a phenotype also observed in *P2ry1* KO mice ([Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"}). Our studies indicate that this phenomenon occurs because P2RY1 controls the volume of the extracellular space in the organ of Corti. Activation of P2RY1 induces ISCs to shrink osmotically (crenate; [Figure 9A](#fig9){ref-type="fig"}), a consequence of ion and water efflux that is triggered by opening of TMEM16A channels ([Figure 4G](#fig4){ref-type="fig"}). The resulting increase in extracellular space lasts for many seconds and enhances dissipation of extracellular K^+^ ([Figure 9A](#fig9){ref-type="fig"}), visible through the time-dependent shift in the reversal potential of K^+^-mediated tail currents ([Figure 4G,I](#fig4){ref-type="fig"}). Conversely, inhibition of P2RY1 increased the size of ISCs, a swelling-induced 'relaxation' that concomitantly decreased extracellular space around IHCs ([Figure 9B](#fig9){ref-type="fig"}). K^+^ accumulation and depolarization of IHCs followed, an effect absent when IHC K^+^ channels were inhibited ([Figure 3J,K](#fig3){ref-type="fig"}) or K^+^ release from cells in the organ of Corti was reduced ([Figure 3H--K](#fig3){ref-type="fig"}), leading to tonic firing of IHCs and post-synaptic SGNs ([Figure 6D,G](#fig6){ref-type="fig"} and [Figure 9B](#fig9){ref-type="fig"}). This phenomenon is consistent with the depolarizing shift in resting membrane potential of IHCs observed in *Tmem16A* cKO mice ([@bib60]), which similarly blocks ISC crenation. Of note, epileptiform activity can be elicited in the CNS by inducing cell swelling with hypoosmotic solutions or by impairing K^+^ buffering ([@bib28]; [@bib35]; [@bib51]). Basal P2RY1 activation in supporting cells hyperpolarizes nearby IHCs by expanding the extracellular space and lowering local K^+^ concentrations. These changes increase the dynamic range of IHCs, allowing them to respond to a wider range of ATP release events and enabling finer control of their excitability through transient ATP-mediated signaling events.

The tonic inward current that develops in ISCs in response to P2RY1 block was abolished when homeostatic K^+^ release pathways (Na^+^ channels, Ca^2+^ channels, Na^+^-K^+^-Cl^--^cotransporters, and Na,K-ATPase) were inhibited ([Figure 3H,I](#fig3){ref-type="fig"}), suggesting that K^+^ redistribution mechanisms, in the absence of ISC crenation, are weak at this stage of development. Indeed, although the membrane potential of ISCs is close to E~K~, their membrane conductance is dominated by intercellular gap junction channels; when uncoupled from their neighbors, they exhibit very high (1--2 GΩ) input resistance ([@bib21]; [@bib60]), suggesting that few K^+^ leak channels are expressed. The presence of tight junctions at the apical surface of the cochlear epithelium and the limited K^+^ conductance of ISCs may restrict passive diffusion and dilution of K^+^, similar to what has been described in the vestibular epithelium ([@bib10]), thus necessitating uptake via alternative mechanisms. Both inner phalangeal and Deiters' cells (which envelop the inner and outer hair cells, respectively) express K^+^-Cl^--^ symporters, Na,K-ATPase pumps, and inwardly-rectifying K^+^ channels that may siphon K^+^ into the supporting cell syncytium after extrusion from hair cells. However, the apparently low capacity of these systems places a greater dependence on diffusion within the extracellular volume fraction controlled by the supporting cells.

Similar to ISCs, astrocytes in the CNS facilitate rapid dissipation of extracellular K^+^ by K^+^ uptake and redistribution through the glial syncytium via gap junctions, a mechanism termed spatial buffering ([@bib25]). Astrocytes are efficient K^+^ sinks due to their highly negative resting potential (\~--85 mV) and large resting K^+^ conductance dominated by inward rectifying K^+^ channels ([@bib38]) and two-pore leak K^+^ channels ([@bib41]). While uptake of K^+^ through these channels is passive, recent studies suggest that K^+^ buffering in astrocytes is actively regulated by purinergic receptors. Following stimulation of native astrocyte purinergic receptors or foreign G~q~-coupled receptors (MrgA1) and release of Ca^2+^ from intracellular stores, Na,K-ATPase activity increased, resulting in a transient decrease in extracellular K^+^, hyperpolarization of nearby neurons, and reduction in their spontaneous activity ([@bib59]). Although P2RY1 is expressed by some astrocytes and can trigger Ca^2+^ waves ([@bib16]), this mechanism does not appear to regulate IHC excitability in the cochlea, as stimulation of P2RY1 in *Tmem16a* cKO mice, which have intact metabotropic receptor signaling but no crenations ([@bib60]), did not hyperpolarize IHCs ([Figure 4I,J](#fig4){ref-type="fig"}). Thus, astrocytes and cochlear ISCs use purinergic signaling in distinct ways to maintain the ionic stability of the extracellular environment and control the excitability of nearby cells.

Role of supporting cells in the generation of spontaneous activity {#s3-3}
------------------------------------------------------------------

Our understanding of how non-sensory cells contribute to spontaneous activity has been limited by a lack of in vivo mechanistic studies. Recent advances in visualizing cochlea-induced spontaneous activity in central auditory centers in vivo using genetically-encoded calcium indicators ([@bib3]) allowed us to assess whether supporting cell purinergic receptors are involved in generating this activity. Prior to hearing onset, the blood-labyrinth barrier within the inner ear is not fully formed ([@bib50]), permitting pharmacological access to the cochlea at this age. Infusion of a P2RY1 inhibitor into the intraperitoneal space dramatically decreased the frequency and amplitude of transient, spatially restricted bands of activity in the inferior colliculus within minutes, while retina-induced activity in the superior colliculus ([@bib1]) was unaffected ([Figure 8](#fig8){ref-type="fig"}), suggesting that inhibition is not due to activation of astrocyte P2RY1 receptors or broad disruption of neural activity; as noted above, inhibition of P2RY1 in astrocytes would be expected to enhance, rather than inhibit neuronal activity ([@bib59]). Within the CNS, *P2ry1* mRNA is expressed in the cochlear nucleus and P2RY1-mediated calcium transients can be induced in spherical bushy cells ([@bib32]). Although the consequences of P2RY1 inhibition on neuronal activity in auditory centers is not yet known, it is possible that some effects of MRS2500 also result from actions on P2RY1 in the CNS.

In vivo imaging in *P2ry1* KO mice recapitulated many aspects of changes seen when P2RY1 was acutely inhibited, with significantly reduced neuronal activity observed in lateral regions of the IC (later active to 8--16 kHz tones; [Figure 7](#fig7){ref-type="fig"}). However, neuronal burst firing persisted within central regions of the IC, regions that will ultimately process lower frequency sounds (3--8 kHz). At present, we do not know the reason for the differences between P2RY1 inhibition and constitutive *P2ry1* deletion, but the absence of P2RY1 throughout development may have induced widespread compensatory changes as a result of the new patterns of activity experienced by these developing neurons ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). Indeed, developing sensory systems exhibit a remarkable ability to preserve spontaneous activity. In the visual system, cholinergic antagonists injected directly into the eye blocks retinal waves in vivo ([@bib1]), but genetic removal of the β2 acetylcholine receptor subunit alters, but does not abolish, peripherally-generated activity ([@bib65]). In the auditory system, in vivo spontaneous activity can be blocked by acute inhibition of cochlear AMPARs, but deaf mice in which hair cell glutamate release is abolished (*Vglut3* KO mice) exhibit activity patterns remarkably similar to control mice ([@bib3]). These robust homeostatic mechanisms allow spontaneous activity to persist despite disruption of key transduction components. Local purinergic signaling within the cochlea may still initiate tonotopic activity in central auditory circuits of *P2ry1* KO mice, perhaps by engaging other subtypes of metabotropic purinergic receptors, as events in the IC exhibited spatial and temporal characteristics similar to controls. IHCs and SGNs are more depolarized in these mice, reducing the threshold for activation by other purinergic receptors. The role of P2RY1 in the developing CNS remains unexplored, but potential compensatory effects may be compounded in central circuits, due to loss of P2RY1 in astrocytes and neurons. Although such gain-of-function changes in the developing nervous system present challenges for interpretation of genetic manipulations, the preservation of early, patterned activity in children that carry deafness mutations may improve the outcome of later therapeutic interventions to restore hearing.

Purinergic receptors in the adult cochlea {#s3-4}
-----------------------------------------

In the adult inner ear, members of all purinergic receptors subtypes (ionotropic P2X receptors, metabotropic P2Y, and adenosine P1 receptors) are expressed by cells throughout the sensory epithelium, Reisner's membrane, stria vascularis, and SGNs ([@bib18]; [@bib20]). The widespread expression of these receptors coupled with observations of increased endolymphatic ATP concentrations following trauma ([@bib34]) have led to the hypothesis that these receptors serve a neuroprotective role. Indeed, infusion of ATP into the inner ear profoundly reduces sound-evoked compound action potentials in the auditory nerve ([@bib5]; [@bib34]), presumably due to decreased endolymphatic potential following shunting inhibition through P2RX2 ([@bib19]) or excitotoxic damage ([@bib8]) to IHCs or SGNs. Consistent with these observations, P2RX2 null mice and humans with a P2RX2 variant (c.178G \> T) experience progressive sensorineural hearing loss ([@bib63]). Ca^2+^ imaging and recordings from adult cochleae have also revealed robust responses to UTP in the inner sulcus, pillar cells, and Deiters\' cells ([@bib45]; [@bib68]), suggesting that metabotropic purinergic receptors continue to be expressed. Following traumatic noise damage, ATP release could activate K^+^ buffering mechanisms in supporting cells, enhance K^+^ redistribution, reduce IHC depolarization and prevent excitotoxic damage. Purinergic receptors may also contribute to IHC gain control by influencing their membrane potential, as ATP circulates in the endolypmph at low nanomolar concentrations ([@bib34]). Further studies involving conditional deletion of *P2ry1* from ISCs in the adult cochlea may help to define the role of this receptor in both normal hearing and injury contexts.

Materials and methods {#s4}
=====================

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                                     Designation                                                  Source or reference                            Identifiers                                                                                Additional\
  (species) or\                                                                                                                                                                                                                                            information
  resource                                                                                                                                                                                                                                                 
  ------------------------------------------------- ------------------------------------------------------------ ---------------------------------------------- ------------------------------------------------------------------------------------------ --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Strain, strain background (Rattus norvegicus)     Sprague Dawley                                               Charles River                                  RRID:[MGI:5651135](https://scicrunch.org/resolver/MGI:5651135)                             

  Strain, strain background (*Mus musculus*)        FVB mice                                                     Charles River                                  RRID:[IMSR_CRL:207](https://scicrunch.org/resolver/IMSR_CRL:207)                           

  Genetic reagent (*Mus musculus*)                  P2ry1tm1Bh;P2ry1 KO                                          ([@bib15])                                     RRID:[MGI:3623279](https://scicrunch.org/resolver/MGI:3623279)                             

  Genetic reagent (*Mus musculus*)                  Pax2-Cre                                                     ([@bib37])                                     RRID:[IMSR_RBRC09434](https://scicrunch.org/resolver/IMSR_RBRC09434)                       

  Genetic reagent (*Mus musculus*)                  R26-lsl-GCaMP3                                               ([@bib39])                                                                                                                                

  Genetic reagent (*Mus musculus*)                  B6.Cg-Snap25tm3.1Hze/J; Snap25-T2A-GCaMP6s                   Jackson Laboratory                             RRID:[IMSR_JAX:025111](https://scicrunch.org/resolver/IMSR_JAX:025111)                     

  Genetic reagent (*Mus musculus*)                  TMEM16Afl/fl                                                 ([@bib43])                                                                                                                                

  Genetic reagent (*Mus musculus*)                  Tecta-Cre                                                    this paper                                                                                                                                A mouseline with Cre expression limited primarily to the sensory epithelium. Cross to TdTomato line reveals sparse labeling of cells within the temporal bone and spiral ganglion neurons.

  Genetic reagent (*Mus musculus*)                  P2ry1tm1(KOMP)Vlcg;P2ry1 LacZ                                KOMP                                           RRID:[IMSR_KOMP:VG12793-1-Vlcg](https://scicrunch.org/resolver/IMSR_KOMP:VG12793-1-Vlcg)   

  Genetic reagent (*Mus musculus*)                  B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J; Ai14; TdTomato   Jackson Laboratory                             RRID:[IMSR_JAX:007909](https://scicrunch.org/resolver/IMSR_JAX:007909)                     

  Antibody                                          Chicken polyclonal anti-beta-gal                             Aves                                           Cat:BGL-1010;RRID:[AB_2313508](https://scicrunch.org/resolver/AB_2313508)                  (1:4000)

  Antibody                                          Rabbit polyclonal anti-Myosin-VIIa                           Proteus Biosciences                            Cat:25--6790; RRID:[AB_2314838](https://scicrunch.org/resolver/AB_2314838)                 (1:500)

  Antibody                                          Donkey anti-chicken Alexa Fluor 488                          Life Technologies                              Cat:ab150073; RRID:[AB_2636877](https://scicrunch.org/resolver/AB_2636877)                 (1:2000)

  Antibody                                          Donkey anit-rabbit Alexa Fluor 546                           Jackson ImmunoResearch                         Cat:711-165-152; RRID:[AB_2307443](https://scicrunch.org/resolver/AB_2307443)              (1:2000)

  Sequence-based reagent                            Primer: cccagttgagattggaaagtg (Snap25GC6s-com-s)             Jackson Laboratory                                                                                                                        

  Sequence-based reagent                            Primer: acttcgcacaggatccaaga (Snap25GC6s-mut-as)             Jackson Laboratory                                                                                                                        

  Sequence-based reagent                            Primer: ctggttttgttggaatcagc (Snap25GC6s-wt-as)              Jackson Laboratory                                                                                                                        

  Sequence-based reagent                            Primer: ccgtcaggacaattatcacc (P2ry1-com-as)                  this paper                                                                                                                                

  Sequence-based reagent                            Primer: cctaccagccctcatcttct (P2ry1-wt-s)                    this paper                                                                                                                                

  Sequence-based reagent                            Primer: cttctatcgccttcttgacg (P2ry1-KO-s)                    this paper                                                                                                                                

  Sequence-based reagent                            Primer: gatggttgtggtgtgtctcg (Tecta-com-s)                   this paper                                                                                                                                

  Sequence-based reagent                            Primer: cagtgatgagggaggaggtg (Tecta-wt-as)                   this paper                                                                                                                                

  Sequence-based reagent                            Primer: cctgtccctgaacatgtcca (Tecta-Cre-as)                  this paper                                                                                                                                

  Sequence-based reagent                            Primer: gctgcctgagttggaaagaa (P2ry1-LacZ-com-s)              this paper                                                                                                                                

  Sequence-based reagent                            Primer: ggcttcatgtggaaaacgaa\                                this paper                                                                                                                                
                                                    (P2ry1-LacZ-wt-as)                                                                                                                                                                                     

  Sequence-based reagent                            Primer: ctctgctgcctcctggcttct (Rosa26-s)                     [@bib39]                                                                                                                                  

  Sequence-based reagent                            Primer: cgaggcggatcacaagcaata (Rosa26-as)                    [@bib39]                                                                                                                                  

  Sequence-based reagent                            Primer: tcaatgggcgggggtcgtt (CMV-E-as)                       [@bib39]                                                                                                                                  

  Sequence-based reagent                            Primer: attcagacggcaaacgactg (P2ry1-LacZ-LacZ-as)            this paper                                                                                                                                

  Sequence-based reagent                            crRNA: TAATGATGAATAATTCATCC (Tecta exon two targeting)       this paper                                                                                                                                

  Chemical compound, drug                           BAPTA-AM                                                     Sigma                                          Cat:A1076; CAS:126150-97-8                                                                 (100 μM)

  Chemical compound, drug                           Thapsigargin                                                 Sigma                                          Cat:T9033; CAS:67526-95-8                                                                  (2 μM)

  Chemical compound, drug                           U73122                                                       Tocris                                         Cat:1268; CAS:112648-68-7                                                                  (10 μM)

  Chemical compound, drug                           U73343                                                       Tocris                                         Cat:4133; CAS:142878-12-4                                                                  (10 μM)

  Chemical compound, drug                           Ryanodine                                                    Tocris                                         Cat: 1329; CAS:15662-33-6                                                                  (10 μM)

  Chemical compound, drug                           MRS2500                                                      Tocris                                         Cat:2159; CAS:630103-23-0                                                                  (1 μM)

  Chemical compound, drug                           PPADS                                                        Sigma                                          Cat:P178; CAS:192575-19-2 (anhydrous)                                                      (100 μM)

  Chemical compound, drug                           Suramin                                                      Sigma                                          Cat:S2671; CAS:129-46-4                                                                    (50 μM)

  Chemical compound, drug                           TTX                                                          Abcam                                          Cat: ab120055;\                                                                            (1 μM)
                                                                                                                                                                CAS: 18660-81-6                                                                            

  Chemical compound, drug                           Ouabain                                                      Tocris                                         Cat: 1076; CAS: 630-60-4                                                                   (10 μM)

  Chemical compound, drug                           Bumetanide                                                   Tocris                                         Cat: 3108; CAS: 28395-03-1                                                                 (50 μM)

  Chemical compound, drug                           CsCl2                                                        Sigma                                          Cat: C4036; CAS: 7647-17-8                                                                 (100 μM)

  Software, algorithm                               ZEN Blue/Black                                               Zeiss                                          RRID:[SCR_013672](https://scicrunch.org/resolver/SCR_013672)                               

  Software, algorithm                               ImageJ                                                       <https://imagej.nih.gov/ij/>                   RRID:[SCR_003070](https://scicrunch.org/resolver/SCR_003070)                               

  Software, algorithm                               MultiStackReg                                                <http://bradbusse.net/sciencedownloads.html>   RRID:[SCR_016098](https://scicrunch.org/resolver/SCR_016098)                               

  Software, algorithm                               MATLAB 2017b                                                 Mathworks                                      RRID:[SCR_001622](https://scicrunch.org/resolver/SCR_001622)                               

  Software, algorithm                               CorelDRAW Graphics Suite                                     Corel                                          RRID:[SCR_014235](https://scicrunch.org/resolver/SCR_014235)                               

  Strain, strain background (*Rattus norvegicus*)   Sprague Dawley                                               Charles River                                  RRID:[MGI:5651135](https://scicrunch.org/resolver/MGI:5651135)                             
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Both male and female mice and rats of postnatal days P6-P8 were used for all experiments and randomly allocated to experimental groups. All animals were healthy and were only used for experiments detailed in this study. Transgenic breeders were crossed to female FVB/NJ (Friend Virus B NIH Jackson; demonstrated low hearing thresholds at 28 weeks) mice to improve litter sizes and pup survival ([@bib67]). Mice were housed on a 12 hr light/dark cycle and were provided food ad libitum. This study was performed in accordance with the recommendations provided in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All experiments and procedures were approved by the Johns Hopkins Institutional Care and Use Committee (protocol \#: M018M330). All surgery was performed under isoflurane anesthesia and every effort was made to minimize suffering.

Electrophysiology {#s4-1}
-----------------

For inner supporting cell recordings, apical segments of the cochlea were acutely isolated from P6-P8 rat ([Figure 1](#fig1){ref-type="fig"}) and mouse pups (all other figures) and used within 2 hr of the dissection. Cochleae were moved into a recording chamber and continuously superfused with bicarbonate-buffered artificial cerebrospinal fluid (1.5--2 mL/min) consisting of the following (in mM): 119 NaCl, 2.5 KCl, 1.3 MgCl~2~, 1.3 CaCl~2~, 1 NaH~2~PO~4~, 26.2 NaHCO~3~, 11 D-glucose and saturated with 95% O~2~/5% CO~2~ to maintain a pH of 7.4. Solutions were superfused at either room temperature or near physiological temperature (32--34°C) using a feedback-controlled in-line heater (Warner Instruments), as indicated in figure legends. Whole-cell recordings of inner supporting cells (ISCs) were made under visual control using differential interference contrast microscopy (DIC). Electrodes had tip resistances between 3.5--4.5 MΩ when filled with internal consisting of (in mM): 134 KCH~3~SO~3~, 20 HEPES, 10 EGTA, 1 MgCl~2~, 0.2 Na-GTP, pH 7.3. Spontaneous currents were recorded with ISCs held at −80 mV.

For inner hair cell recordings, apical segments of the cochlea were acutely isolated from P6-P8 mouse pups and used within 2 hr of the dissection. Cochleae were moved into a recording chamber and continuously superfused with bicarbonate-buffered artificial cerebrospinal fluid (1.5--2 mL/min) consisting of the following (in mM): 115 NaCl, 6 KCl, 1.3 MgCl~2~, 1.3 CaCl~2~, 1 NaH~2~PO~4~, 26.2 NaHCO~3~, 11 D-glucose. Solutions were saturated with 95% O~2~/5% CO~2~ to maintain a pH of 7.4. Solutions were superfused at room temperature. Electrodes had tip resistances between 4.5--6 MΩ when filled with internal consisting of (in mM): 134 KCH~3~SO~3~, 20 HEPES, 10 EGTA, 1 MgCl~2~, 0.2 Na-GTP, pH 7.3. For hair cell recordings with K^+^ channels inhibited with cesium and TEA, the internal solution consisted of (in mM): 100 cesium methanesulfonate, 20 TEA-Cl, 10 EGTA in CsOH, 20 HEPES, 1 MgCl~2~, 0.2 Na-GTP, pH 7.3 with CsOH. Spontaneous currents were recorded with IHCs held at near their resting membrane potential (--75 to --80 mV).

Errors due to the voltage drop across the series resistance and the liquid junction potential were left uncompensated for recordings of spontaneous activity. For IHC recordings with K+ accumulation voltage protocols ([Figure 4](#fig4){ref-type="fig"}), the amplifier compensation circuit was used to compensate 70% of the access resistance. Recordings that displayed more than a 10% increase in access resistance or access resistances \> 30 MΩ were discarded. ISC and IHC spontaneous currents were recorded with pClamp 10 software using a Multiclamp 700B amplifier, low pass filtered at 2 kHz, and digitized at 5 kHz with a Digidata 1322A analog-to-digital converter (Axon Instruments).

For SGN juxtacellular recordings, cochleae were dissected and cultured for 2 days (see Cochlear Explant Culture section below). Cochleae were then transferred to a recording chamber and continuously superfused with bicarbonate-buffered aCSF (same as ISCs) at 1.5--2 mL/min. Recordings were performed at room temperature. Electrodes for SGN recordings had tip resistances between 1.5--2.5 MΩ when filled with artificial cerebrospinal fluid. Extracellular potentials were recorded for 10 min with pClamp10 software using a Multiclamp 700B amplifier, low pass filtered at 20 kHz, and digitized at 50 kHz with a Digidata 1322A analog-to-digital converter (Axon Instruments). For MRS2500 experiments, spikes were analyzed in five-minute windows; five minutes of baseline preceded ten minutes of superfusion of aCSF containing 1 μM MRS2500. Firing behavior in the latter five minutes of MRS2500 was used for measurement.

Action potentials were analyzed offline using custom routines written in Matlab 2017b (Mathworks). Briefly, raw traces were high-pass filtered to remove baseline drift and spikes were identified using an amplitude threshold criterion. As described previously ([@bib55]), bursts were identified by classifying interspike intervals into non-bursting intervals (\>1 s), burst intervals (30 ms - 1 s), and mini-burst intervals (\<30 ms). Bursts were defined as clusters of at least 10 consecutive burst intervals (with mini-burst intervals being ignored in the context of burst detection). Spikes within mini-bursts were included when calculating the number of spikes within a burst. Colored raster plots were generated by grouping spikes into one-second bins and applying a color map to the resulting data (modified 'hot' colormap; Matlab).

Cochlear explant culture {#s4-2}
------------------------

Cochleae were dissected from postnatal day 5--6 control (*P2ry1+/+* or *Pax2-Cre;R26-lsl-GCaMP3*) and *P2ry1* KO (*P2ry1*^--^*^/^*^--^or *Pax2-Cre;R26-lsl-GCaMP3;P2ry1*^--^*^/^*^--^) mice in ice-cold, sterile-filtered HEPES-buffered artificial cerebrospinal fluid (aCSF) consisting of the following (in mM): 130 NaCl, 2.5 KCl, 10 HEPES, 1 NaH~2~PO~4~, 1.3 MgCl~2,~ 2.5 CaCl~2~, and 11 D-Glucose. Explants were mounted onto Cell-Tak (Corning) treated coverslips and incubated at 37° C for 24--48 hr in Dulbecco's modified Eagle's medium (F-12/DMEM; Invitrogen) supplemented with 1% fetal bovine serum (FBS) and 10 U/mL penicillin (Sigma) prior to recording or imaging.

Transmitted light imaging {#s4-3}
-------------------------

Cochlear segments were imaged with a Olympus 40x water immersion objective (LUMPlanFl/IR) and recorded using MATLAB and a USB capture card (EZ Cap). Difference movies were generated by subtracting frames at time t~n~ and t~n+5~ seconds using ImageJ software to generate an index of transmittance change over time. To quantify transmittance changes, a threshold of three standard deviations above the mean was applied to the values. To calculate the frequency of these events, the whole field was taken as an ROI and peaks were detected using MATLAB (findpeaks function). To calculate area of these events, a Gaussian filter (sigma = 2.0) was applied to the image after thresholding and the borders detected using MATLAB (bwlabel function). The area was then calculated as the number of pixels within the border multiplied by the area scaling factor (µm/pixel)^2^ measured with a stage micrometer.

Immunohistochemistry and X-gal reaction {#s4-4}
---------------------------------------

Mice were deeply anesthetized with isoflurane and perfused with freshly prepared paraformaldehyde (4%) in 0.1 M phosphate buffer. Cochleae were post-fixed for 45 min at room temperature and stored at 4°C until processing. For X-gal reactions, P6-P8 cochleae were removed from the temporal bone and washed 3 × 5 min with PBS. Tissue was then incubated for 24 hr in the dark at 37°C in X-gal working solution consisting of (in mM): five potassium ferricyanide crystalline, five potassium ferricyanide trihydrate, two magnesium chloride, and 0.1% X-gal (GoldBio) dissolved in DMSO. After washing 3 × 5 min with PBS, images of cochleae were acquired on a dissecting microscope (Zeiss Stemi 305). For immunohistochemistry, fixed tissue was washed 3 × 5 min in PBS, placed in 30% sucrose solution overnight, and incubated in OCT mounting medium overnight at 4°C. Ten micron thick cross-sections of the cochlea were made on a cryostat and mounted on Superfrost Plus slides (Fisher), which were then allowed to dry for 1 hr before processing. Cross-sections were incubated overnight with primary antibodies against β-gal (anti-Chicken; 1:4000, Aves) and Myosin-VIIa (anti-Rabbit; 1:500, Proteus BioSciences) for detection of β-gal and with Myosin-VIIa only for qualitative analysis of the *Tecta-Cre;TdT* reporter mouse line. Sections were then rinsed three times with PBS and incubated for two hours at room temperature with secondary antibodies raised in donkey (Alexa-488 and Alexa-546; 1:2000, Life Technologies). Slides were washed three times in PBS (second with PBS + 1:10,000 DAPI), allowed to dry, and sealed using Aqua Polymount (Polysciences, Inc). Images were captured using a laser scanning confocal microscope (LSM 510 or 880, Zeiss).

Confocal imaging of explants {#s4-5}
----------------------------

After one day in vitro, cochleae were moved into a recording chamber and continuously superfused with bicarbonate-buffered artificial cerebrospinal fluid (1.5--2 mL/min) consisting of the following (in mM): 119 NaCl, 2.5 KCl, 1.3 MgCl~2~, 1.3 CaCl~2~, 1 NaH~2~PO~4~, 26.2 NaHCO~3~, 11 D-glucose, and saturated with 95% O~2~/5% CO~2~ to maintain a pH of 7.4. A piezo-mounted objective was used to rapidly alternate between SGN cell bodies and ISCs/IHCs. Images were captured at one frame per second using a Zeiss laser scanning confocal microscope (LSM 710, Zeiss) through a 20X objective (Plan APOCHROMAT 20x/1.0 NA) at 512 × 512 pixel (354 × 354 µm; 16-bit depth) resolution. Sections were illuminated with a 488 nm laser (maximum 25 mW power). MRS2500 (1 µM, Tocris) was applied by addition to the superfusing ACSF.

Analysis of in vitro Ca^2+^ transients {#s4-6}
--------------------------------------

Images were imported into ImageJ and image registration (MultiStackReg) was used to correct for drifts in the imaging field. Since images were obtained at two different z-planes, images were combined into one stack for analysis. This was done by eliminating the empty bottom half of the imaging field containing ISCs and IHCs and the empty top half of the field containing SGN cell bodies and merging the two images. For analysis of coordinated activity throughout the cochlea, regions of interest were drawn around the entirety of ISCs, IHCs, and SGNs. Fluorescence changes were normalized as ΔF/F~o~ values, where ΔF = F -- Fo and F~o~ was defined as the fifth percentile value for each pixel. Peaks in the signals were detected in MATLAB using the built-in peak detection function (findpeaks) with a fixed value threshold criterion (mean + three standard deviations for each cell).

To quantify frequency and areas of Ca^2+^ transients, a threshold of three standard deviations above the mean was applied to each pixel within the ROI. To calculate the frequency of these events, the whole field was taken as an ROI and peaks were detected using MATLAB (findpeaks function) on the number of thresholded pixels per frame. To calculate area of these events, a Gaussian filter (sigma = 2.0) was applied to the image after thresholding and the borders detected using MATLAB (bwlabel function). The area was then calculated as the number of pixels within the border multiplied by an area scaling factor (1 µm/pixel)^2^ measured with a stage micrometer.

For correlation analysis, ROIs were drawn around every IHCs in the field of view. Pairwise correlation coefficients were performed between every hair cell pair and represented as correlation matrices.

Installation of cranial windows {#s4-7}
-------------------------------

Inhalation anesthesia was induced with vaporized isoflurane (4% for 5 min, or until mice are non-responsive to toe-pinch) and surgical plane maintained during the procedure (with 1--2% isoflurane) with a stable respiration rate of 80 breaths per minute. A midline incision beginning posterior to the ears and ending just anterior to the eyes was made. Two subsequent cuts were made to remove the dorsal surface of the scalp. A headbar was secured to the head using super glue (Krazy Glue). Fascia and neck muscles overlying the interparietal bone were resected and the area bathed in sterile, HEPES-buffered artificial cerebrospinal fluid that was replaced as necessary throughout the surgery. Using a 28G needle and microblade, the sutures circumscribing the interparietal bone were cut and removed to expose the midbrain. The dura mater was removed using fine scissors and forceps, exposing the colliculi and extensive vasculature. A 5 mm coverslip (CS-5R; Warner Instruments) was then placed over the craniotomy, the surrounding bone was dried using a Kimwipe, and super glue was placed along the outer edges of the coverslip for adhesion to the skull. Replacement 0.9% NaCl solution was injected IP and a local injection of lidocaine was given to the back of the neck. Animals were weaned off isoflurane, placed under a warming lamp, and allowed to recover for a minimum of 1 hr prior to imaging. Spontaneous activity was not seen in deeply anesthetized animals and emerged \~30 min after recovery from isoflurane exposure, as reported previously ([@bib1]).

In vivo calcium imaging {#s4-8}
-----------------------

After 1 hr of post-surgical recovery from anesthesia, pups were moved into a swaddling 15 mL conical centrifuge tube. The top half of this tube was removed to allow access to the headbar and visualization of the midbrain. Pups were head-fixed and maintained at 37°C using a heating pad and temperature controller (TC-1000; CWE). During the experiments, pups were generally immobile; however, occasional limb and tail twitching did occur.

For wide field epifluorescence imaging, images were captured at 10 Hz using a Hamamatsu ORCA-Flash4.0 LT digital CMOS camera attached to a Zeiss Axio Zoom.V16 stereo zoom microscope. A 4 × 4 mm field of view was illuminated continuously with a metal halide lamp (Zeiss Illuminator HXP 200C) and visualized through a 1X PlanNeoFluar Z 1.0x objective at 17x zoom. Images were captured at a resolution of 512 × 512 pixels (16-bit pixel depth) after 2 × 2 binning to increase sensitivity. Each recording consisted of uninterrupted acquisition over 10 min or 20 min if injected with pharmacological agents.

Catheterization of animals for in vivo imaging {#s4-9}
----------------------------------------------

After induction of anesthesia and before installing the cranial window, a catheter was placed in the intraperitoneal (IP) space of neonatal mouse pups. A 24G needle was used to puncture the peritoneum and a small-diameter catheter (SAI Infusion Technologies, MIT-01) was placed. A drop of Vetbond secured the catheter to the pup's belly. Installation of cranial window proceeded as described above.

Imaging sessions consisted of 5 min of baseline activity measurements, followed by a slow push of either 50 µL of sham (5% mannitol solution) or MRS2500 solution (500 µM in 5% mannitol solution). Imaging was continuous throughout and 20 min of activity total were collected. No discernable diminishment of activity was observed in sham animals.

Image processing {#s4-10}
----------------

For wide field imaging, raw images were imported into the ImageJ environment and corrected for photobleaching by fitting a single exponential to the fluorescence decay and subtracting this component from the signal (Bleach Correct function, exponential fit). Images were then imported into MATLAB (Mathworks) and intensities were normalized as ΔF/F~o~ values, where ΔF = F -- F~o~ and F~o~ was defined as the fifth percentile value for each pixel. Ovoid regions of interest (ROIs) encompassing the entire left and right inferior colliculi were drawn. Across all conditions, the size of the ROIs was invariant, however, due to small differences in the imaging field between animals, the ROIs were placed manually for each imaging session. Peaks in the signals were detected in MATLAB using the built-in peak detection function (findpeaks) using a fixed value threshold criterion; because fluorescence values were normalized, this threshold was fixed across conditions (2% ΔF/F~o~). Occasionally, large events in the cortex or superior colliculus would result in detectable fluorescence increases in the IC. These events broadly activated the entire surface of the IC and did not exhibit the same spatially-confined characteristics as events driven by the periphery. These events were not included in the analysis.

Analysis of spatial distribution of activity in the IC {#s4-11}
------------------------------------------------------

As shown in [Figure 6D](#fig6){ref-type="fig"}, a rectangle of size 125 × 50 pixels was placed perpendicular to the tonotopic axis of the IC (±55° rotation, respectively). The columns of the resulting matrix were averaged together to create a line scan (125 pixels x one pixel) for the entire time series. Peaks were detected using MATLAB's imregionalmax function with a constant threshold of 3% ΔF/F~o~ across all animals. Histograms of events along the tonotopic axis were generated by summing the number of events in \~25 µm bins. Lateral and medial designations were assigned by splitting the area evenly between the lateral edge and the location of defined single-band events in the medial portion of the IC. Events detected on the medial edge of single-band events, reflective of the bifurcation of this information was not included in the medial/lateral analysis.

Analysis of retinal wave activity in the superior colliculus {#s4-12}
------------------------------------------------------------

ROIs (200 × 150 pixels) were placed over each lobe of the superior colliculus and downsampled by a factor of five. Signals were normalized as ΔF/F~o~ values, where ΔF = F -- F~o~ and F~o~ was defined as the fifth percentile value for each pixel. In order to eliminate periodic whole-sample increases in fluorescence, the mean intensity of all pixels was subtracted from each individual pixel. Following this, pixels were considered active if they exceeded the mean + three standard deviations. For each point in time, the number of active pixels was summed. Retinal waves were defined as prolonged periods (\>1 s), where more than five pixels were active simultaneously. Retinal wave durations were defined as the total continuous amount of time that more than five pixels were active. Frequencies and durations are similar to earlier reports ([@bib1]).

Generation of the Tecta-Cre mouseline {#s4-13}
-------------------------------------

A crRNA (TAATGATGAATAATTCATCC) targeted near exon 2 of the *Tecta* gene, tracrRNA, Cas9 recombinase, and a donor plasmid containing an iCre-WPRE-polyA sequence (500 base pair homology arms) were injected into single-cell embryos that were then transferred to pseudopregnant recipient mothers. After birth, mouse pups were screened for insertion of the gene at the correct locus with two pairs of primers: one pair amplified DNA beginning 5' of the 5' homology arm and ending within the Cre sequence and the other amplified DNA within the polyA sequence and ending 3' of the 3' homology arm. These primers were then used to sequence the junctions. Of these, all mice used for experiments were derived from a single founder that was positive for both sets of primers and had 100% sequence validation. Mice were crossed to a TdTomato reporter line to examine cell-specific recombination.

Quantification and statistical analysis {#s4-14}
---------------------------------------

All statistics were performed in the MATLAB (Mathworks) programming environment. All statistical details, including the exact value of n, what n represents, and which statistical test was performed, can be found in the figure legends. To achieve statistical power of 0.8 with a 30% effect size with means and standard deviations similar to those observed in previous studies (Figure 1E of [@bib52] and Figures 1B and 3D in [@bib61]), power calculations indicated that seven animals in each condition are necessary (µ~1~ = 10, µ~2~ = 7, σ = 2, sampling ratio = 1). While this number was used as a guide, power calculations were not explicitly performed before each experiment; many experiments had much larger effect sizes and sample sizes were adjusted accordingly. For transparency, all individual measurements are included in the figures. Unless otherwise noted, data are presented as mean ± standard error of the mean (SEM). Because the main comparison between conditions was the mean, the SEM is displayed to highlight the dispersion of sample means around the population mean. All datasets were tested for Gaussian normality using the D'Agostino's K^2^ test. For single comparisons, significance was defined as p\<=0.05. When multiple comparisons were made, the Bonferroni correction was used to adjust p-values accordingly to lower the probability of type I errors. For multiple condition datasets, one-way ANOVAs were used, followed by Tukey's multiple comparison tests.
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

This study employs an impressive combination of methods to investigate the mechanisms that trigger spontaneous patterned activity in mouse inner hair cells prior to hearing onset. This spontaneous activity is conveyed along the auditory pathway and is thought to play an important role in the development of the auditory system. Building on previous work by the authors showing that ATP release is involved in this process, the present study uses pharmacological tools and knockout mice to demonstrate that purinergic signaling in supporting cells, mediated by P2RY1 autoreceptors, regulates hair cell excitability by controlling the volume of the extracellular space. Clear evidence is presented that this results from crenation -- osmotic shrinkage -- of the supporting cells, which increases the extracellular space. This study therefore provides insight into the mechanisms that initiate intrinsically generated bursts of activity in the developing auditory system, abnormalities of which may contribute to certain developmental hearing disorders.

**Decision letter after peer review:**

Thank you for submitting your article \"Supporting cells in the cochlea reduce hair cell excitability by increasing the extracellular space\" for consideration by *eLife*. Your article has been reviewed by Andrew King as the Senior Editor and Reviewing Editor, and three reviewers. The following individuals involved in review of your submission have agreed to reveal their identity: Ivan Milenkovic (Reviewer \#1); Christian Lohr (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

The reviewers were all enthusiastic about the paper, which they felt was appropriate for *eLife*. Although they did not indicate that additional experimental work is essential, a concern was raised about the discrepancy between the reported effect of UTP (agonist at P2Y2, P2Y4 and P2Y6 receptors) in recent publications and the apparently exclusive effect of P2Y1 ligands in the present manuscript. This issue needs to be addressed, if necessary, with additional data. Furthermore, the reviewers all felt that some of the findings have been over-interpreted and that the paper is currently difficult to follow due to the wealth of manipulations and different approaches used.

Essential revisions:

1\) One of the main conclusions is that P2Y1-induced SC crenation is temporally matched by the shift in the IHC potassium current (Figure 4). This is assumed to change the burst structure recorded in spiral ganglion neurons (Figure 6). Indeed, the 75-125 ms interspike intervals are strongly reduced, while the remaining ones are shifted to longer values. The time constant for crenations is about 40 ms, and 100 ms for the potassium current. MRS2500 completely blocks spontaneous currents in the IHCs before the late inward current arises (Figure 3F,G). How does MRS2500 eliminate the whole bursts and the spikes within a burst in Figure 6A-F? Moreover, the spiking under MRS2500 is transiently abolished prior to firing at even higher rate, presumably due to increased excitability. These temporal relationships between the crenations, changes in potassium current direction, and the loss of interspike intervals should be better elaborated and discussed.

2\) Although the MRS2500 injection experiments in Figure 8 show a profound reduction of activity in the IC, it is not possible to exclude the possibility of P2Y1 inhibition elsewhere in the auditory pathway. For instance, cochlear nucleus bushy cells express P2Y1 (Milenkovic et al., 2009) and it is conceivable that some other neurons may express them too. The assumption that MRS2500 crosses the blood-brain barrier only in the cochlea seems unjustified. Due to the inaccessibility of the cochlea for a local drug application, the authors performed what is feasible, but they should clearly discuss that this may not be a cochlea-specific effect.

3\) In their recent publications (Tritsch and Bergles, 2010; Wang et al., 2015), the authors showed that UTP is as potent as ATP in triggering the signaling cascade that results in IHC depolarization. UTP is not a potent agonist at P2Y1 receptors, but rather stimulates P2Y2, P2Y4 and to some extent P2Y6, suggesting that several P2Y receptor subtypes might be involved. It is surprising that the authors have not even mentioned this discrepancy. They show that selective stimulation of P2Y1 with MRS2365 fails to induce currents and crenation in inner supporting cells of P2Y1 KO mice, which is expected given that MRS2365 is selective for P2Y1. Is the UTP-evoked effect also suppressed in P2Y1 KO mice (or by blocking P2Y1 with MRS2500 in wildtype mice)? Spontaneous activity in inner supporting cells and IHCs is entirely suppressed by the P2Y1 antagonist MRS2500 with no further effect of suramin/PPADS, suggesting no major contribution of other P2Y receptors. What is the role of UTP-sensitive P2Y receptors in purinergic activity in the developing cochlea? This issue should at least be discussed.

4\) The reviewers disagreed with the assertion in the subsection "Supporting cell spontaneous currents require calcium release from intracellular stores" that U73122 has a dramatic effect on the frequency of spontaneous currents and crenation. In Figure 1D,E, the effect is not even significant compared to U73343, which was used as negative control. The lack of a complete block by U73122 (which would be expected at the concentration of 10µM), and no difference in the effect between the blocker and the inactive analogue, raise the question of whether calcium is released from the ER solely via IP3. In line with this, neither BAPTA nor Thapsigargin are specific for the Gq pathway, as stated in the legend for Figure 1C. Both drugs would have the same effect if the calcium is released via RyRs. Thus, the conclusions about the sole contribution of the Gq pathway may not be fully justified.

5\) Statistics: Please explain the power calculation more thoroughly at least for one example. From what type of data in the literature do you expect a 30% effect size and 20% SD?

6\) The manuscript uses SEM in the figures. The choice of SEM over SD should be justified, and all the data points shown (this is done for most but not all panels). The number of animals in addition to number of cells should be reported.

7\) Figures: in some cases, it is difficult to find the age of the animal for a given figure panel. Please specify this in all figure legends.

8\) Differences in Figure 7 and Figure 8 are in some cases subtle or not significant, but these results are underemphasized in the overall interpretation of the results. The Introduction sets up the problem in an overly dichotomous perspective regarding importance of different mechanisms for generating spontaneous activity. A more helpful treatment would consider both ISC activity and efferent activity as essential parts of the overall process.

9\) The Discussion section should consider how the whole cycle might be regulated at the macroscopic level. What initiates release of ATP from the supporting cells?

10\) Possible CNS effects on results in KO mice are considered, but the logic of these needs to be explained a bit more.
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Author response

> Essential revisions:
>
> 1\) One of the main conclusions is that P2Y1-induced SC crenation is temporally matched by the shift in the IHC potassium current (Figure 4). This is assumed to change the burst structure recorded in spiral ganglion neurons (Figure 6). Indeed, the 75-125 ms interspike intervals are strongly reduced, while the remaining ones are shifted to longer values. The time constant for crenations is about 40 ms, and 100 ms for the potassium current. MRS2500 completely blocks spontaneous currents in the IHCs before the late inward current arises (Figure 3F,G). Moreover, the spiking under MRS2500 is transiently abolished prior to firing at even higher rate, presumably due to increased excitability.
>
> How does MRS2500 eliminate the whole bursts and the spikes within a burst in Figure 6A-F?

Application of MRS2500 blocks P2RY1-mediated spontaneous currents (Figure 3B,F), eliminating large transient increases in extracellular K^+^ (Figure 4G) and therefore IHC burst firing (Figure 6D). Just as activation of P2RY1 increases the extracellular space by causing supporting cell shrinkage, inhibition of P2RY1 causes supporting cells to expand, decreasing the extracellular space. This decrease in the extracellular volume leads to accumulation of K^+^ (Figure 3B,H), resulting in slow depolarization (Figure 3F) and tonic (non-burst) firing of IHCs (Figure 6D). Thus, P2RY1 antagonism shifts SGNs from a burst firing mode to random firing, leading to loss of bursts and spikes within a burst.

> These temporal relationships between the crenations, changes in potassium current direction, and the loss of interspike intervals should be better elaborated and discussed.

To clarify the temporal relationship between these events more clearly, we now include a summary figure detailing the time course of these discrete events (Figure 9), and have expanded the discussion of the sequence of changes that lead to the shift in firing behavior of SGNs when P2RY1 is inhibited (subsection "Control of extracellular K^+^ dynamics by supporting cells").

> 2\) Although the MRS2500 injection experiments in Figure 8 show a profound reduction of activity in the IC, it is not possible to exclude the possibility of P2Y1 inhibition elsewhere in the auditory pathway. For instance, cochlear nucleus bushy cells express P2Y1 (Milenkovic et al., 2009) and it is conceivable that some other neurons may express them too. The assumption that MRS2500 crosses the blood-brain barrier only in the cochlea seems unjustified. Due to the inaccessibility of the cochlea for a local drug application, the authors performed what is feasible, but they should clearly discuss that this may not be a cochlea-specific effect.

We agree that MRS2500 may also act on P2RY1 receptors in the CNS, and did not mean to imply that this compound only has access to the cochlea. The preservation of retina-induced activity in the SC (Figure 8) after MRS2500 administration suggests that global changes in neuronal activity are not affected by this drug; however, it is possible that there may be specific roles for P2RY1 in the auditory pathway, as *P2ry1* mRNA is expressed in the cochlear nucleus and P2RY1-mediated calcium transients can be induced in spherical bushy cells (Milenkovic et al., 2009). At present, we do not know the conditions under which these receptors would be activated or what effect their inhibition would have on the propagation of bursts of activity to the IC. The discussion of CNS P2RY1 receptors has been expanded to address this possibility (subsection "Role of supporting cells in the generation of spontaneous activity").

> 3\) In their recent publications (Tritsch and Bergles, 2010; Wang et al., 2015), the authors showed that UTP is as potent as ATP in triggering the signaling cascade that results in IHC depolarization. UTP is not a potent agonist at P2Y1 receptors, but rather stimulates P2Y2, P2Y4 and to some extent P2Y6, suggesting that several P2Y receptor subtypes might be involved. It is surprising that the authors have not even mentioned this discrepancy. They show that selective stimulation of P2Y1 with MRS2365 fails to induce currents and crenation in inner supporting cells of P2Y1 KO mice, which is expected given that MRS2365 is selective for P2Y1. Is the UTP-evoked effect also suppressed in P2Y1 KO mice (or by blocking P2Y1 with MRS2500 in wildtype mice)? Spontaneous activity in inner supporting cells and IHCs is entirely suppressed by the P2Y1 antagonist MRS2500 with no further effect of suramin/PPADS, suggesting no major contribution of other P2Y receptors. What is the role of UTP-sensitive P2Y receptors in purinergic activity in the developing cochlea? This issue should at least be discussed.

The reviewers raise an important issue regarding the complement of different P2Y receptors expressed by supporting cells in the cochlea. We did not directly address this question in this study and our experiments do not rule out the possibility that supporting cells express other P2Y receptors. Our focus was to identify which purinergic receptors are responsible for spontaneous activity. The SHIELD gene expression database reveals the mRNAs for *P2ry1, P2ry2* and *P2ry4* G~q~-coupled receptors are present, although *P2ry2* and 4 mRNA are present at much lower levels than *P2ry1* (100x less, Figure 2A, Scheffer et al., 2015). Our experiments demonstrate that P2RY1 is both necessary and sufficient to generate transient inward currents in supporting cells. Applying a P2RY1-specific agonist, MRS2365, generates large inward currents (Figure 4B,C) and applying a P2RY1 antagonist, MRS2500, eliminates large spontaneous inward currents (Figure 3B,C), an effect also observed in *P2ry1* KO mice (Figure 3---figure supplement 2). Additionally, large calcium transients are abolished in supporting cells by acute P2RY1 inhibition or genetic deletion (Figure 5 and Figure 5---figure supplement 1). Together, these data suggest that, if other P2Y autoreceptors are expressed, they are not principally involved in generating spontaneous activity.

Our prior studies and gene expression analyses suggest that inner supporting cells express a variety of functional P2X and P2Y receptors, which can be activated by exogenous agonists. We do not know why these other receptors are not activated in inner supporting cells during spontaneous events. It is possible that the ATP is rapidly hydrolyzed to ADP by extracellular nucleotidases, limiting activation of P2X receptors, and the much greater abundance of P2RY1 may enable preferential activation of these receptors, particularly if the amount of ATP released is low. Further in vivogenetic and pharmacological manipulations will be required to define the conditions under which these receptors are activated and their consequences for spontaneous and evoked activity. We have expanded discussion of these issues (subsection "Control of extracellular K^+^ dynamics by supporting cells" and subsection "Purinergic receptors in the adult cochlea").

> 4\) The reviewers disagreed with the assertion in subsection "Supporting cell spontaneous currents require calcium release from intracellular stores" that U73122 has a dramatic effect on the frequency of spontaneous currents and crenation. In Figure 1D,E, the effect is not even significant compared to U73343, which was used as negative control. The lack of a complete block by U73122 (which would be expected at the concentration of 10µM), and no difference in the effect between the blocker and the inactive analogue, raise the question of whether calcium is released from the ER solely via IP3. In line with this, neither BAPTA nor Thapsigargin are specific for the Gq pathway, as stated in the legend for Figure 1C. Both drugs would have the same effect if the calcium is released via RyRs. Thus, the conclusions about the sole contribution of the Gq pathway may not be fully justified.

As noted, the PLC inhibitor did not abolish spontaneous currents in supporting cells, raising the possibility that there are other mechanisms responsible for the spontaneous calcium transients. The significant decrease in frequency of inward currents and crenations by U73211 (Figure 1C,F) supports the involvement of PLC, and is consistent with the canonical signal transduction mechanism expected for P2RY1; however, it is possible that calcium stores could be mobilized by activation of ryanodine receptors (RyRs) via other purinergic receptors. To explore this possibility, we examined the effect of acute exposure to ryanodine (10 µM) on ISCs. This manipulation did not decrease either spontaneous inward currents or crenations, which is now included as a new figure (Figure 1---figure supplement 1) and described in subsection "The metabotropic purinergic receptor P2Y1 is highly expressed by supporting cells". These findings are consistent with information from the SHIELD database, which suggests that RyRs are not expressed highly by supporting cells (*Ryr1*: 1-4 normalized reads between E16 and P7, *Ryr2*: 2-44 normalized reads, *Ryr3*: 0-7 normalized reads, *P2ry1*: 1010-1742 normalized reads; Scheffer et al., 2015).

We revised the Figure legend text (1C) to remove references to the G~q~ pathway.

> 5\) Statistics: Please explain the power calculation more thoroughly at least for one example. From what type of data in the literature do you expect a 30% effect size and 20% SD?

References to previous studies using similar techniques are now included in the subsection "Quantification and Statistical Analysis". In Figure 1E of Tritsch et al., 2007 and in Figures 1B and 3D in Wang et al., 2015, standard deviations range from \~15 to 25%. A 30% effect size was selected as a conservative estimate. Our previous studies have shown that effect sizes when spontaneous activity is pharmacologically or genetically altered is much higher (between 50 and 90%; Tritsch et al., 2007, Wang et al., 2015).

> 6\) The manuscript uses SEM in the figures. The choice of SEM over SD should be justified, and all the data points shown (this is done for most but not all panels). The number of animals in addition to number of cells should be reported.

Justification for the use of SEM is now included in subsection "Quantification and Statistical Analysis*"*. Briefly, SEM was chosen as it shows the dispersion of sample means around the population mean. Because the means of measurements are being compared across conditions, we feel that the SEM provides more valuable information for visual comparison than the SD, which provides information about the variability of the sample. All individual data points are included, and the number of animals has been added to the figure legends.

> 7\) Figures: in some cases, it is difficult to find the age of the animal for a given figure panel. Please specify this in all figure legends.

All experiments were performed in P6-8 animals. This information has been added to the figure legends.

> 8\) Differences in Figure 7 and Figure 8 are in some cases subtle or not significant, but these results are underemphasized in the overall interpretation of the results. The Introduction sets up the problem in an overly dichotomous perspective regarding importance of different mechanisms for generating spontaneous activity. A more helpful treatment would consider both ISC activity and efferent activity as essential parts of the overall process.

We observed differences in *P2ry1* KO mice and the response to acute inhibition of P2RY1. The effects of the acute P2RY1 inhibition, both in excised cochlea (Figure 3, Figure 5, Figure 6) and in vivo (Figure 8) are highly significant. However, differences between control and *P2ry1* KO mice were, in some cases, subtle (Figure 7), as noted. We do not yet know the explanation for these differences but expect that constitutive loss of P2RY1 throughout development leads to compensatory alterations. Indeed, our studies indicate that IHCs are more depolarized in *P2ry1* KO mice, suggesting that they may be more sensitive to other excitatory influences. While we did not directly address the role of efferents in generating spontaneous activity, our excised cochleae do not have CNS input, recent in vivo recordings from *alpha9* KO mice (Clause et al., 2014) and our own in vivo imaging studies from these animals (unpublished) indicate that spontaneous activity persists in the absence of efferent cholinergic input to IHCs. We did not intend to imply that efferents play no role in spontaneous activity and now more explicitly define the potential roles of supporting cells and efferents in the Introduction and subsection "Purinergic signaling in the developing cochlea").

> 9\) The Discussion section should consider how the whole cycle might be regulated at the macroscopic level. What initiates release of ATP from the supporting cells?

Unfortunately, we do not yet know how ATP is released by supporting cells. The available data suggest that a gap-junction hemichannel might be responsible, as gap-junction inhibitors profoundly inhibit spontaneous activity, and lowering extracellular calcium, a manipulation that increases the open probability of hemi-channels (Peracchia, 2004), enhances the frequency of spontaneous activity (Tritsch et al., 2007). Moreover, our unpublished results indicate that inhibiting vesicular loading with bafilomycin-A does not alter spontaneous activity in supporting cells. However, due to cochlear expression of many gap-junction family members and other potential ATP-release channels (VRACs, maxi-anion, pannexins) (Lautermann et al., 1998, Zhang et al., 2005, Scheffer et al., 2015) and the absence of specific pharmacological agents to inhibit these channels, it has not yet been possible to explore this question further. We now address this issue briefly in subsection "Purinergic signaling in the developing cochlea".

> 10\) Possible CNS effects on results in KO mice are considered, but the logic of these needs to be explained a bit more.

It is difficult to predict what compensatory changes might occur without P2RY1, as little is known about the role of P2RY1 in the CNS or even the broader role of purinergic receptors in CNS development. The most notable effect of P2ry1 KO is the depolarization of IHCs, which may enhance the effect of previously minor/subthreshold events. Enhanced, non-purinergic spontaneous activity is also evident in supporting cells from *P2ry1* KO mice, raising the possibility of other gain-of-function changes. These changes are now discussed (subsection "Purinergic receptors in the adult cochlea").

[^1]: Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, United States.
